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INTRODUCTION 
The Siddha system dates back to 5000 B.C profounded by Saint Agathiyar and his  
clan numbering 18 such Siddhars. This system was an amalgam of  Tamil literature, 
culture, tradition, health and many such living forms of 64 types. 
The Department of Gunapadam in National Institute of Siddha, Chennai is 
functioning from 30/9/2004 and many such research works had been carried out 
successfully.. 
The current research was on Indhuppu bhavanai to evaluate the safety and 
pharmacological activities in animal models. 
The drug Indhuppu bhavanai wasindicated for Pitha Gunmam (Hyperacidity) 
which was selected from the Siddha literature“Kadukkai vallaraiin thani maanbu” third 
edition-1992, pg.no: 84, authored by Hakkim P. Mohammed Abdulla sayub. 
All the ingredients were identified and authenticated by the experts and the test 
drug was prepared by the given procedure. 
Review of literature in various categories were carried out.Siddha aspect, botanical 
aspect and mineralogical aspect disclosed about the drug and the disease, which strongly 
supports that it possesses anti- ulcer (Hyperacidity),anti-inflammatory and analgesic 
activities,  for that purpose it has been selected for this study  
The drug was subjected to analysis such as physicochemical, 
phytochemical,chemical and also instrumental analysis which provided the key ingredients  
present in the drug thus it accounts the efficacy of the drug 
Preclinical evaluation of acute and Repeated  dose 28 day oral toxicity study was 
carried out in K.K College of Pharmacy, Gerugambakkam and Repeated dose 90 day oral 
toxicity study of the drug was carried out in the Animal house, NIS, Chennai.  
Wistar  albino rats of  either sex of weight 150-200 gm were used for toxicity and 
pharmacological studies. The animals were kept under standard conditions 
12:12(day/night cycles) at room temperature in polypropylene cages. The animals were 
fed on standard pelleted diet and potable water in polypropylene bottles ad libitum. The 
animals were housed for one week prior to the experiments to acclimate to animal house 
conditions. 
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In acute toxicity study, various dose levels of Indhuppu bhavanai5, 50, 300 and 
2000 mg/kg b.w. was administered to female wistar albino rats which showed no 
abnormalities in external observation and necropsy examination and all the vital organs 
were normal. 
In Repeated  dose 28 day oral toxicity study and Repeated dose 90 day oral toxicity 
studies, various doses level of Indhuppu bhavanai at 900mg/kg and 1800 mg/kg was 
administered orally, did not show any  significant changes in hematological parameters 
and histopathological slides of various organs. 
In Pharmacological studies,Anti-ulcer (Hyperacidity), anti-inflammatory and 
analgesic activities of the drug was carried out in wistar albino rats and mice as per OECD 
guideline in K.K College of Pharmacy, Gerugambakkam revealed that the drug Indhuppu 
bhavanai exhibited significant anti-ulcer, anti-inflammatory and analgesic activities.  
 
 The above studies showed that the drug Indhuppu bhavanai was safe in animal studies 
and may be carried  for clinical trial. 
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2. AIM AND OBJECTIVES 
 AIM 
 The aim of the study was to evaluate the Safety and Pharmacological profile of the 
test drug “INDHUPPU BHAVANAI’’ in animal models. 
 
OBJECTIVE 
      The following methodology was adopted to evaluate the Safety and 
Pharmacological activities of the test drug. 
 
 Review of various information (Siddha and modern) relevant to the study. 
 Preparation of the drug as per classical Siddha literature. 
 Analytical study of  the  prepared drug  
 Physicochemical and phytochemical analysis 
 Chemical analysis to evaluate acidic and basic radicals. 
 Elemental analysis 
 Analysis of Particle size 
 
 Screening the toxicity in animal models. 
 Acute oral toxicity study  (OECD – 423 Guideline) 
 Repeated dose 28 dayoral toxicity (OECD – 407 Guideline) 
 Repeated dose 90 day oral  toxicity  (OECD – 408 Guideline) 
 
 Evaluation of pharmacological activities in animal models. 
 Anti -ulcer    (Aspirin induced  ulcer model) 
 Anti -inflammatory (Cotton pellet induced granuloma method) 
 Analgesic   (Eddy’s hot plate method) 
 
 
 
 
  
 
 
Materials and 
methods 
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3. MATERIALS AND METHODS 
STANDARD OPERATIVE PROCEDURE OF INDHUPPU BHAVANAI 
Drug selection 
 The drug Indhuppu Bhavanai, a herbo-mineral formulation was taken as a trial 
drug from Siddha literature Kadukkai Vallaraiin Thani Maanbu, third edition-1992, 
pg.no: 84 ,Author:Hakkim P. Mohammed Abdulla sayub 
 The Ingredients of Indhuppu Bhavanaiare, 
(3)
    
1. Purified Indhuppu (Sodium chloride impura)   –  5 palam (175 g)  
2. Vallarai leaf juice(Centella asiatica) 
3. Lemon pulp juice (Citrus limon)  
4. Purified fresh Ginger juice (Zingiber officinale)  Required volume 
5. Nellikai pulp juice (Phyllanthus emblica) 
 
Collection of the Plant materials 
 All plant materials were freshly collected from Tambaram sanatorium, Tamilnadu. 
Indhuppu was procured from a well reputed country shop in Parrys, Chennai. Indhuppu 
was purified and the medicine was prepared in the Gunapadam laboratory of National 
Institute of Siddha. 
Identification and Authentication of the drug 
 Mineral drug was authenticated by the Chemist in Central Research Institute of 
Siddha, Arumbakkam, Chennai.  
The Herbal drugs were Identified and authenticated by the Botanist, National 
Institute of Siddha. 
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Bhavanai
(1) 
Bhavana was a process in which powders were soaked in various fluids, such as 
the expressed juice of herbs, decoctions etc., and then dried. For this purpose the quantity 
of juice added to the powder should be sufficient to cover it. The mixture is then allowed 
to dry in a shaded place. This process is repeated twice or thrice or as many times, as in 
necessary.       
Purification process 
Indhuppu
(2)
 
Indhuppu was dissolved in vinegar and kept for 3 days and dried in sunlight. 
Preparation of the drug 
(3)
 
 Indhuppu was placed in Kalvam and powdered. Vallarai juice was poured until 
Indhuppu was immersed. 
 Then it was grinded slowly till it loses moisture content and becomes dry and the 
same process was repeated for 7 times. 
 Then the above mentioned process was carried out with the following juices 
respectively, 
 - Lemon juice 
 - Ginger juice 
 - Goose berry  juice 
Finally powder was dried & preserved. 
 
Labelling 
   
Name of the preparation : Indhuppu Bhavanai 
Date of preparation  : 15/6/2015 
Dose    : 1 gm bd 
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Adjuvant/Vehicle  : Honey 
Indications   : Pitha gunmam (hyperacidity), Vaanthi   
     (Vomiting), Vayitru eraichal (Gastric   
     irritation), Seriyaamai (Indigestion), Vaayu   
     muthaliya irappai sampanthamana noigal  
     (Gastro intestinal disorders) theerum. 
Date of expiry   : 100 years from the date of manufacture  
 
   INDHUPPU BHAVANAI 
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INGREDIENTS OF INDHUPPU BHAVANAI 
 Indhuppu        
Before purification      After purification 
    
VALLARAI (Centella asiatica)   INJI (Zingiber officinalae)  
  
 
ELUMICHAI (Citrus limon)    Nellikai (Phyllanthus emblica) 
 
 
  
 
 
Review of literature 
 
 
 
 
 
  
 
 
Gunapadam review 
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GUNAPADAM REVIEW 
,e;Jg;G -   INDHUPPU 
NtW ngah;fs; 
 ire;jtk;> rpe;J}uk;> re;jpuDg;G> kjp$h;ik> kjpAg;G> kpe;jhr;nrhy;. 
 ,J xU kz;g+j ruf;fhFk;. 
 ,jpy; gr;irf; fw;g+uk; kbAk;> g+uk; Kg;ghFk;. 
nra;if 
 kyfhhpr; nra;if 
nghJFzk; 
ml;l Fd;k ke;jk; mrph;f;fuQ;#h; rPjgpj;je; 
Jl;litak; ehbg;Gz; Njhlq;;fs;- nfl;lkyf; 
fl;Ltpl tpe;ijaf; fhkpaNeha; td;fug;ghd; 
tpl;Ltpl tpe;Jg;ig tps;. 
nrd;dpf;fz;zh gw;W}h; nrtpfTs;fz; lk;gfNeha; 
re;epah rq;fhre; jhfkpiug;-Gd;dpuj;j 
%yQ; rpye;jpesp %bfeQ; #ij typ 
#yQ; rpijAkpe;jhw; nrhy;. 
nghUs; 
 vz;tpj Fd;kk;> myrk;> mrph;f;fuk;> euk;Gf;fpue;jp> fLtd;> kyge;jk;> tplk;> 
jphpNjhlk;> fghjpf;fk;> jiy> tpop> eh> je;j%yk;> jhJ> fd;dk;> fz;lk;> Nahdp 
,t;tplj;J Neha;fs;> ,uj;j %yk;> Rthrk;> rpye;jp> Njs;> vyp ,tw;wpd; tplq;fs;> 
#iy jPUk;. 
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kUj;Jt gad;fs; 
 ,e;Jg;ig Njfj;jpy; RSf;F te;jhy; gw;W Nghlyhk;. 
 ,e;Jg;ig typAld; $ba tPf;fq;fSf;F #lhf;fp xw;wlk; ,lyhk;. 
,e;Jg;G NrUk; gpw kUe;Jfs; 
1) ,e;Jg;Gr; #uzk;  
2) rq;fj; jpuhtfk; 
3) mw;Gj khj;jpiu  
4) rpj;jhjp vz;nza;  
5) et cg;G nkOF  
6) Fd;kFNlhhp nkOF  
7) gQ;rytz gw;gk;  
8) ehAUtp cg;ghjpf; Fok;G 
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ty;yhiu -  VALLARAI 
NtW ngah ;fs;
(5)
 : rz;lfp> gpz;lfp> Nahrdty;yp 
Botanical name  : Centella asiatica (Linn.) 
English name  : Indian Pennywort 
Family  : Apiaceae 
 
gad;gLk; cWg;G  
  G+z;L 
Organoleptic characters 
Rit   : Jth;g;G> ifg;G> ,dpg;G  
jd;ik : : jl;gk;  
gphpT   : ,dpg;G 
nra;if  
 clw;Nww;wp 
 cukhf;ffp 
nghJFzk; 
mf;fu Neha; khWk; mfYk; tapw;wpopT 
jf;ftpuj; jf;fLg;Gj; jhNdFk; - gf;fj;jpy; 
vy;yhiu AkUe;njd; NwAiuj;J ed;kidAs; 
ty;yhiu iatsh;j;J it.    (Njiuah; Fzthflk;) 
 
nghUs; 
 tha;g;Gz;> fopr;ry;> FUjpf; fopr;ryhy; gpwf;Fk; tapw;Wf; fLg;G ePq;Fk;. 
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kUj;Jt gad;fs; 
 ,iyia miuj;Jf; fl;l> ahidf;fhy;. tpiu tPf;fk;> thA tPf;fk;> 
mbgl;lj; jir rpije;Jz;lhd tPf;fk; NghFk;. 
 Foe;ijfSf;Fz;lhFk; rPjf;fopr;ry;> FUjpf; fopr;ry;> tapw;Wf; fLg;G 
KjypaitfSf;F mjd; ,iyia miuj;Jf; nfhg;G+o; kPJ gw;wpl 
mitfs; ePq;Fk; 
 ,iyAld; nte;jaKk; Nrh;j;J FbePhpl;L 1> 2 rq;F Foe;ijfSf;Fg; Gfl;l> 
Ruk;> tapw;Wf; NfhshWfs; Nghk;. 
 ty;yhiu ,iy nghbapy; 130-300 kp.fp vLj;J gRtpd; ghypy; fye;J 
nfhLf;f> Qhgf rf;jp cz;lhFk;. %isAk; gyg;gLk;. 
 ty;yhiu ,iy nghbia Gz;fs; kPJ J}tp tu Gz;fs; vspjpy; MWk;. 
 
ty;thiu NrUk; gpw kUe;Jfs; 
1) ty;yhiu nea; 
2) mkph;jrQ;rPtp Nyfpak; 
3) ty;yhiu kzg;ghF 
4) jphpgiy khj;jpiu 
5) kpsF gf;Ftk; 
6) jphpfLF khj;jpiu 
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vYkpr;ir  - Citrus limon 
NtW ngah;fs;
(5)
 : rk;gPuk; 
English name  : Lime 
Botanical name : Citrus limon (Linn) Burm.f. 
Family  : Rutaceae 
gad;gLk; cWg;G 
 gok;> gourk; 
Organoleptic characters 
,iy> fha;> gok;  
 Rit       :  Gspg;G  
jd;ik      :  ntg;gk;  
gphpT       : fhh;g;G 
nra;if 
gok;  : Fsph;r;rpAz;lhf;fp 
nghJFzk; 
gok; 
jhfk; FefNeha; jhohr; rpypgjNeha; 
Ntfq;nfhs; cd;khjk; tPWgpj;jk;- khfz;Nzha; 
Fd;dNdha; the;jpAk;Nghq; fl;Lth jpj;njhopypy; 
Kd;ndYkpr; rq;fdpia tho;j;J.   (mfj;jpah; Fzthflk;) 
 
nghUs; : 
 kaf;fk;> the;jp> tha;f;Fkl;ly;> ePh;Ntl;if> ntwp> fz;Nzha;> fhJtyp 
NghFk;. 
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rk;gPuk; 
ke;jphpf;F ke;jphpaha; kd;dDf;F kd;dnddj; 
je;jphpf;F kpj;jpud;Nghw; rhUNk- Ke;jtU 
fk;gPu kha;r;ruf;fpd; nfz;zpakha; thflh;f;Fr; 
rk;gPu khnkYkpr; ir.     (Njud; fhg;gpak;) 
 
nghUs; 
 vYkpr;rk; gok; ke;jphp vdf;$Wk; jPf;Fw;wj;ijj; jzpf;Fk;;;> je;jphpahfpa 
Iaj;jpw;F md;gd;NghypUe;J mdy; tsh;f;Fk;.   (Nj.ntz;gh) 
kUj;Jt gad;fs; 
 ,g;gourj;NjhL rh;f;fiu $l;b ePh; Nrh;j;Jg; ngUf;fp ePh;tplha;f;F 
mUe;jyhk;. 
 vYkpr;rk;goj;ij fw;gKiwaha;g; gj;jpaj;Jld; MWkhjq; nfhs;s gpbg;G> 
ngUtapW> gf;f#iy> Klk;> kdr;Nrhh;T> kaf;fk; jPUk;. 
 gts gw;gj;ij ,g;gor; rhw;Wld; Nrh;j;J rPjf; fopr;ry;> ngUq; fopr;ry;> 
mjprhu fopr;ry; ,itfSf;Ff; nfhLf;fyhk;. 
 rPufj;ij Njd; tpl;Lg; nghd;tWtyhf tWj;J> ,jd; gourj;ijr; Nrh;j;J 
ePh;tpl;Lf; fha;r;rpf; nfhLf;f> clNd the;jpAk; fopr;rYk; epw;Fk;. 
vYkpr;ir NrUk; gpw kUe;Jfs; 
1) rpe;jhjp Nyfpak; 
2) g+h;zhjp Nyfpak;  
3) jhk;gpu gw;gk; 
4) ,ytz gw;gk; 
5) fypq;fhjp vz;nza; 
6) ,Q;rp Nyfpak; 
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,Q;rp  - Zingiber officinale 
NtW ngah;fs;
(5)
 : my;yk;> Mh;j;jufk;> Mj;jpufk;> ,yhf;nfhl;il>  
    eWkUg;G kjpy; 
English name  : Green ginger fresh root 
Botanical name : Zingiber officinale 
Family  : Zingiberaceae 
gad;gLk; cWg;G  
 fpoq;F 
Organoleptic characters 
Rit  :  fhh;g;G 
jd;ik     :  ntg;gk;  
gphpT   : fhh;g;G 
nra;if 
 mfl;Ltha;tfw;wp 
 grpj;jPj;J}z;b 
 ckpo;ePh;g;ngUf;fp 
 nrhpg;Gz;lhf;fp 
 
nghJFzk; 
,Q;rpf; fpoq;Ff; fpUky;Iak; Xf;fhsk; 
tQ;rpf;FQ; rd;dpRuk; td;Ngjp- tpQ;Rfpd;w 
#iyaWk; thjk;Nghe; J}z;lhj jPgdkhk; 
NtiyAWq; fz;zha;- tpsk;G   (mfj;jpah; Fzthflk;) 
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,Q;rpapd; FzNk njd;wp ay;Gl Diuf;ff; NfsPh; 
mQ;rpLQ; rd;dpnay;yh kfd;wpLk; gpj;j Njhlk; 
neQ;rpdp ypUkw; Nfhio nefpo;e;jpLk; fgq;fs; jd;id 
kpQ;rpdp tUNkh ntd;W tpsk;gpLk; Njt E}Ny   (VL) 
 
nghUs; 
,Q;rpapdhy; moy;Fw;wk;> tsp#iy> Kf;Fw;w Neha;fs;> nrhpahf;fopr;ry; 
NghFk;. grpAz;lhFk;. 
kUj;Jt gad;fs; 
 mfl;ilg; gw;wpa tapw;W typ> tapw;Wg; nghUky; the;jp> Fly; Neha;> 
Kjypa Neha;fSf;F ,Q;rpia NjD}wy; nra;J nfhLf;fyhk;. 
 nrhpahf; fopr;rYf;F ,Q;rpr; rhw;iw> njhg;Gisr; Rw;wpj; jltTk;. 
 ,Q;rpr; rhWk;> ntq;fhar; rhWk; tiff;F xU Njhyh tPjk; vLj;Jf; 
fye;Jf; nfhLf;f the;jp> Xf;fhsk; jPUk;. 
 ,Q;rpia ghypy; miuj;Jf; fow;rpasT 18 kp.ypl;lh; ghypy; fye;J fhiy 
khiy nfhLj;Jtu ,Uky;> ,isg;G> Fd;kk;> kaf;fk;> moy; tha;T jPUk;. 
,Q;rpNrUk; gpw kUe;Jfs; 
1) ehuq;fhjp Nyfpak; 
2) ,Q;rp Nyfpak; 
3) rpe;jhjp Nyfpak; 
4) g+h;zhjp Nyfpak; 
5) Gspahiu nea; 
6) ,Q;rp #uzk; 
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ney;yp - Phyllanthus emblica 
NtW ngah;fs;
(5) 
 : Mkyfk;> Myfk;> Mk;gy;> Mkhpfk;> jhj;jhhp>  
    jhj;jphp> Nfhuq;fk;> kpWJgyh> kPJe;J   
Botanical name : Phyllanthus emblica. Linn 
English name  : Indian gooseberry 
Family  : Euphorbiaceae 
 
gad;gLk; cWg;G  
 fha; 
Organoleptic characters 
Rit   :  Gspg;G> Jth;g;G> ,dpg;G 
jd;ik :  jl;gk; 
gphpT  : ,dpg;G 
nra;if 
gok;  : Fsph;r;rpAz;lhf;fp 
       
nghJFzk; 
gpj;jkd iyak; gPeprk;tha; ePh; the;jp 
kj;jkyf; fhLk; kaf;fKkpy;-xj;jTU 
tpy;ypf;fh ak;kUq;fh nkd;dhl;fh ye;Njh;e;Nj 
ney;ypfh ak;kUe; JzP.    (Njiuah; Fzthflk;) 
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ney;ypf;fha;f; Fg;gpj;jk; ePq;F kjd;Gspg;ghy; 
nry;YNk thjkjpw; Nrh;Jtuhy;- nrhy;Yikak; 
XLkpijr; rpj;jj;jpy; cd;d mdYlNd 
$Lgpw NkfKk; Nghq; $W.    (Njiuah; Fzthflk;) 
 
nghUs; : 
the;jp> kaf;fk;> tha;ePh;r; Rug;G jPUk;. mjd; Gspg;ghy; Jth;g;ghy; IaKk; 
ePq;Fk;.  
kUj;Jt gad;fs; 
 ney;ypf;fhiaj; Jitay; nra;J rhg;gpl> Ritapd;ik> the;jp ,itfisg; 
Nghf;Fk;. 
 ney;yptw;wiyf; FbePh; nra;J nfhLf;f kaf;fk;> jhfk;> Xf;fhsk; ePq;Fk;. 
 ,iyf; nfhOe;ij miuj;J Nkhhpy; fye;J rPjf;fopr;rYf;Ff; nfhLf;fyhk;. 
 
ney;ypf;fha;NrUk; gpw kUe;Jfs; 
1) rugq;f tpy;thjp Nyfpak; 
2) ehuj;ij Nyfpak;  
3) ,Q;rp Nyfpak; 
4) ney;ypf;fha; Nyfpak; 
5) fhprhiy Nyfpak; 
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4.2 BOTANICAL ASPECT 
VALLARAI  - CENTELLA ASIATICA
 
Synonym
(6) 
 : Hydrocotyle asiatica Linn 
Family  : Apiaceae 
Vernacular names  
Tamil  : Vallarai , Chandaki 
English : Indian pennywort 
Hindi  : Khulakudi 
Parts used 
 Leaf 
Organoleptic characters 
Taste  : Astringent, bitter, sweet 
Nature : Neutral 
Division : Sweet 
Action 
 Alternative, Tonic, Diuretic, Stimulant, Emmenogogue. 
Chemical constituents 
Leaves : Essential oil, fatty oil, sitosterols, tannin and resinous  substances 
Plant  : Triterpenoid asiatocoside – A and B 
Major Chemical constituents
(8)
 
 Madecassoside, Asiaticoside, Asiatic acid, Brahmic acid  
19 
 
Minor chemical constituents 
  Asiaticoside B, Brahminoside, Brahmoside, Centelloside, Indcentelloside, 
Thankuniside, Isothankuniside, Brahmic acid, Isobrahmic acid, Betulic acid, Centic acid, 
Centoic acid and flavanoid glycosides. 
RESEARCH ARTICLE RELATED TO THE STUDY 
Acute and sub acute toxicity study
(9) 
 Acutetoxicity study of Centella asiatica revealed that the drug at the  dose of 
10gm/kg did not cause any toxic signs and death within the observation period of 14 days. 
 Sub chronic toxicity study of ECa233 at the doses of 10, 100,1000 mg/kg/day 
showed no difference with regards to body weight, food consumption and health in 
comparison to the control group except that female rats  receiving 1000mg/kg/day of 
ECa233 had significantly higher white blood cell counts than the control group. 
Pharmacological activities 
Anti ulcer activity 
(10) 
 The research article revealed that the Centella asiatica extract  of dose 100mg/kg, 
200mg/kg, 400mg/kg exhibited protection of gastric mucosal layer. Histopathological 
studies reveals  reduction or absence of edema and leucocytes infiltration of submucosal 
layer. It also possess analgesic and anti- inflammatory activity 
(34) 
Medicinal uses
(7) 
 The extract from the plant promotes epithelialisation and a very early decrease in 
the wound surface area. 
 It cures haemorrhagic diseases and heart trouble, efficacious in skin affections, 
anorexia, subduces deranged pitta. 
  The leaves of Centellia asiatica is fried in castor oil and applied over swellings in 
elephantiasis and  scrotal swelling. 
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Elumichai   -  Citrus limon 
Synonym
(6)
  : Citrus medica L. 
Family  : Rutaceae 
Vernacular names 
Tamil   : Elumichchai, arasakani, Kesari 
Hindi   : Nimbu 
English  : Acid lime, limon 
Parts used 
Fruit 
Organoleptic Characters 
Unripe fruit, fruit 
Taste   : Sour 
Nature   : Hot 
Division  : Acrid 
Action 
Lemon juice   : Refrigerent, antiscorbutic action 
fruit   : Refrigerant 
Chemical constituents 
        Lemons are a rich source of vitamin C. Lemons contain numerous phytochemicals, 
including polyphenols and terpenes. Abscisic acid, Gibberellic acid, Limonin, Linoleic 
acid, Ascorbic acid, Carotenoids, Pantothenic acid, pectin and vitamin B1. Fresh lemon 
juice contains minerals such as Zinc, Selenium, Manganese, Iron, Sodium, Chloride, 
Calcium.It also contains Vitamin A, Niacin, Vitamin C,Vitamin E and Vitamin K. As with 
other citrus fruits, they have significant concentrations of citric acid (about 47 g/l in juice). 
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RESEARCH ARTICLES RELATED TO THE STUDY 
Anti-ulcer activity
(33) 
The research article revelaed that the healthy male albino wistar rats of weight      
200-250 g were pretreated with the extract of Citrus medica at the dose level of 250 mg 
kg-1 and 500mg/kg-1 showed a significant reduction in ulcer formation. Histopathological 
sections showed significant decrease in mucosal ulceration, inflammatory mucosal 
changes and submucosal edema compared to ethanol treated group and ranitidine group. 
 It is concluded that the fruits of Citrus medica possesses significant anti-ulcer 
activity against ethanol-induced ulcers in rats and the anti-ulcer activity could be due to 
the presence of flavonoids as these compounds have well documented anti-ulcer activity. 
Analgesic activity
(11)
 
 The research article revealed that the fruit decotion of Citrus medica Linn. were 
found to be effective in a dose level of 4ml/kg which inhibited the pain produced by the 
hot plate. Thus it is concluded that this study validates the traditional use of Citrus medica 
Linn. as an analgesic. 
Medicinal uses
(7) 
 The fruit is efficacious in the treatment of vomiting and gastric stimulant. 
 The ripe fruit is highly appetizing.  
 It is highly recommended in rheumatism affections such as plerodynia, 
sciatica, lumbago, pain in the hip joints.  
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Zinziber officinale  - Inji 
Vernacular names
(6) 
Tamil  : Inchi, allam, ilaakottai, narumaruoou mathil 
English : Ginger 
Hindi  : Adrakh 
Parts used  
        Bulbous root or rhizome 
Organoleptic characters 
Taste  : Acrid 
Nature  : Hot 
Division : Acrid 
Action 
Stimulant, Carminative, Stomachic, Sialagogue, Digestive, Rubefacient 
Chemical constituents
(8) 
Major: 
 Gingerol, α – Zingiberene, β- sesquiphellandrene and ar - curcumene, Lipids, 
Proteins and Starch. 
Minor: 
 Gingerdiols,  
 Gingerdiacetates,  
 Gingerdiones,  
 Diterpenes, 6- gingersulfonic acid,  
 Gingerglycolipids A, B and C. 
 
23 
 
RESEARCH ARTICLES RELATED TO THE STUDY 
Toxicity study
(12)
 
 The research article revealed that the aqueous extract of gingiber rhizome at the 
dose of 2g/kg b.w. for 14 days indicated that there were no lethal effect upto 1g/kg b.w. 
and no adverse effect on the major organs. 
Pharmacological activity
(13) 
 The research article revealed that the aqueous extract of ginger root extract of dose 
200mg/kg, 400mg/kg when administered to rats, the percentage inhibition of gastric ulcer 
was 40.91%, 57.58% respectively. 
 This shows that the ginger root extract  significantly inhibited the gastric damage 
induced by indomethacin and its efficacy as a gastro protective agent was comparable to 
that of  Omeprazole.  
 Another study reveals that the active components in ginger root could have an 
antisecretory activity and cytoprotection by increasing mucus wall thickness. 
 Ginger and its constituents act as digestive aids: possess antiulcer
(18-24)
, Cholagogic 
(25)
and antiemetic
(26-28)
 properties. 
Medicinal uses
(7)
 
 Ginger decotion is giver for colic pain, tympanites and vomiting. 
 It is aromatic and beneficial in dropsy , dyspepsia, digestive and stomachic. 
 Ginger  juice  rubbed on and around navel cures all kinds of diarrhoea. 
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Emblica officinalis - Nellikai 
Synonyms
(6) 
 : Phyllanthus emblica Linn.; Cicca emblica Kurz  
Common name :  Emblic myrobalan, Indian Goose berry. 
Family   : Euphorbiaceae 
Vernacular names 
Tamil   : Nelli 
English  : Gooseberry 
Hindi   : Amlika 
Parts used 
 Fruit 
Organoleptic characters 
Taste   : Astringent, sweet, sour 
Nature   : Neutral 
Division   : Sweet 
Action 
Fruit   : Diuretic, refrigerant, laxative 
Chemical Constituents
(8) 
Fruit     
 Trigalloyiglucose, terchebin, covilagin, ellagic acid, phyllembic acid 
 Vitamin C, Gallic acid, Ellagic acid, Phyllemblic acid, emblicol 
 Phyllantidine, Phyllantine, Pectin, Minerals 
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RESEARCH ARTICLES RELATED TO THE STUDY 
Acute toxicity study
(14)
 
The acute and chronic toxicity study revealed that the hydroalcoholic extract of 
amla (HAE) was prepared and was administered at the dose of  250, 500 and 1000 mg/kg 
body orally does not cause any mortality up to 48 hr. Hence the LD50 of Emblica 
officinalis is more than 1000 mg/kg and there was no untoward effect and no gross 
observational effects were observed at any dose of Emblica officinalis. 
Pharmacological activity
(16) 
 The research article revealed that the aqueous extract of Phyllanthus emblica            
(PE-AqE 47) when administered to rats inhibited the H.pylori growth while its 
antisecretory, anti-ulcer and gastroprotective effects may be due to its potent antioxidant 
characteristics. Its significant ulcer protective and healing effects and this might be due to 
its effects both on offensive and defensive mucosal factors.  
 
Medicinal uses
(7)
 
 It is effective in the treatment of peptic ulcer(25-27) and dyspepsia(28). 
 The leaves of Phyllanthus emblica is boiled in water and goggled for mouth 
ulcers.Decoction of goose berry will remove excessive thirst, giddiness and 
vomiting sensation.  
 Fruits are good liver tonic. The fruit juice is useful in indigestion, jaundice, 
anaemia, heart complaints. It is a rich source of vitamin C.  
 
 
 
 
 
 
  
 
 
Mineralogical review 
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4.3  MINERALOGICAL ASPECT 
Sodium Chloride Impura – Rock salt 
Vernacular  names 
Tamil  : Indhuppu 
Eng  : Rock salt 
Hindi  : Sendhalon 
 Halite commonly known as rock salt, is the mineral form of sodium chloride 
(NaCl). Halite forms isometriccrystals.  
Source 
 Found in nature in extensive beds mostly associated with clay and calcium 
sulphate. 
Characters 
 It is found in small white crystalline grains or transparent cubes.  
 It is brownish white externally and white internally.  
 It has a pure saline taste and burns with a yellow flame. 
Physicochemical properties 
 Category  : Halide mineral 
 Chemical formula : NaCl 
 Crystal symmetry : Isometrical hexoctahedral 
 Molar mass  : 58.433g/mol 
 Crystal system : Cubic 
 Luster   : Vitreous 
 Streak   : White 
 Optical properties : Isotropic 
 Refractive index : 1.544 
 Solubility  : Water soluble 
 Other characters : Salty flavour, Fluorescent 
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Action 
 Carminative 
 Stomachic  
 Digestive 
Medicinal uses 
 It is given in dyspepsia and other abdominal disorders. 
 It promotes the appetite and assists digestion and assimilation. 
 It is made into a paste and applied in case of sprain 
 Hot fomentation of the rock salt can be taken for curing the painful swellings. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Analytical study of 
Indhuppu bhavanai 
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5. ANALYTICAL STUDY OF THE DRUG INDHUPPU BHAVANAI 
Analytical study of the drug brings the validation to be used as a medicine by  
subjecting the drug to many analysis and determining its quality and effectiveness. 
Analytical study includes many studies such as its organoleptic properties, physico 
chemical properties and phytochemical properties and also to assess the active principles 
and elements present in the drug. Thus analytical study brings the efficacy and potency of 
the drug. 
As per AYUSH protocol for analytical study, the following parameters were 
evaluated. 
Analytical study of the drug includes: 
 Organoleptic characters 
 Colour 
 Odour 
 Taste  
 Texture 
 Physicochemical analysis 
 Determination of Ash Values 
 Physical characterization 
 Phytochemical analysis 
HPTLC and TLC finger print analysis 
 Chemical analysis 
Preliminary Basic and Acidic radical studies 
 Elemental analysis 
Inductively Coupled Plasma Optical Emissions Spectrometry (ICP- OES) 
 Analysis of particle size 
 Scanned Electron Emission (SEM) 
 
 
  
 
 
Physico chemical 
analysis 
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5.1 Organoleptic characterization of  Indhuppu bhavanai 
The organoleptic characters of the sample drug were evaluated. 1gm of the test 
drug was taken and the following characters were seen. 
Colour, Odour, Taste, Texture and other morphology were viewed  by naked eye 
under sunlight. Then the result was noted. 
 
Colour 
The medicine was taken into watch glasses and placed against white back ground 
in white tube light. It was observed for its colour by naked eye. 
Odour 
The medicine was smelled individually. The time interval among two smelling was 
kept 2 minutes to nullify the effect of previous smelling. 
The results of Organoleptic character were showed in table - 1 
 
5.2 PHYSICOCHEMICAL ANALYSIS 
Physicochemical studies of the trial drug have been done according to the WHO 
guidelines 
Physical properties of Indhuppu bhavanai 
The physical properties of Indhuppu bhavanai was analyzed at Captain Srinivasamurti 
Reseach Institute for Ayurveda and Siddha Drug Development, Arumbakkam, Ch-106. 
 
1.Determination of pH:  
Five grams of Indhuppu bhavanai was weighed accurately and placed in clear 100 
ml beaker. Then 50 ml of distilled water was added to it and dissolved well. After 30 
minutes it was then applied in to pH meter at standard buffer solution of 4.0, 7.0, and 9.2. 
Repeated the test four times and average was recorded. 
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2.Loss on drying of the sample at 105ºC  -  
4g of test drug was weighed in a previously weighed 100ml beaker and heated in 
an oven at 105ºC for 5hours. Cooled in a dessicator and weighed.  Repeated the procedure 
till constant weight was obtained.  The percentage loss in weight of the test drug was 
calculated by the following formula. 
Calculation: 
                                                                               Loss in weight of test drug 
Percentage of loss on drying at 105ºC   =   ------------------------------------------------ x 100 
                                                                               Weight of test drug taken 
 
3.Ash content  
Total ash content  
4g of test drug was weighed accurately in a previously ignited and tared silica dish.  
The material was evenly spread and ignited in a muffle furnace at 600⁰C until it became 
white indicating the absence of carbon.  The dish was cooled in a dessicator and weighed.   
As carbon free ash cannot be obtained in this manner, the dish was cooled and the residue 
moistened with 2 sufficient quantity of water.  Dried on a water bath and then ignited in 
the electric furnace to get the constant weight. Cooled the dish in a dessicator and then 
weighed. The percentage of total ash of air-dried materials was calculated as per the 
formula given below.  
Calculation: 
                                       Weight of the ash   
Percentage of total ash   =   --------------------------------- x 100 
                                       Weight of test drug taken 
 
4.Acid-insoluble ash  
     The total ash of the test drug was found out as described above. To the dish containing 
the total ash was added 45 ml of 1: 5 hydrochloric acid in three portions of 13 ml each 
time.  Boiled gently for 5 minutes and filtered. Collected the insoluble matter on an ashless 
filter paper (Whatman No.41) and washed with distilled water until the residue was free 
from acid.  Transfer the filter paper containing the insoluble mater to the original dish.  
Dried and ignited to the constant weight. Cooled the dish in a dessicator, and then 
weighed.  Calculation was made by given formula. 
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 Calculation: 
                                      Weight of the acid-insoluble residue   
Percentage of acid-insoluble ash   =   -------------------------------------------- x 100 
                                                             Weight of test drug taken 
 
5.Water-soluble extractive of the test drug 
       4 g of the test drug was weighed accurately in a glass stoppered flask. Added 100 ml 
of distilled water and shacked occasionally for 6 hours and then allowed to stand for 18 
hours. Filtered rapidly taking care not to lose any solvent and pipetted out 25 ml of the 
filtrate in a pre weighed 100 ml beaker and evaporated to dryness on a water bath. Kept in 
an air oven at 105ºC for 6 hours.  Cooled in a dessicator and weighed.  Repeated the 
experiment twice, and taken the average value. The percentage of water soluble extractive 
was calculated by the formula given below. 
Calculation: 
                                                                   Weight of the extract            100 
Percentage of water soluble extract   =   -------------------------------- x --------- x 100  
                                                                   Weight of sample taken         25 
 
6.Alcohol-soluble extractive of the sample   
       4 g of the sample was weighed accurately in a glass stoppered flask. Added 100 ml of 
distilled alcohol (approximately 95%) and shaken occasionally for 6 hours and then 
allowed to stand for 18 hours.  Filtered rapidly taking care not to lose any solvent and 
pipetted out 25 ml of the filtrate in a pre weighed 100 ml beaker and evaporated to dryness 
on a water bath. Kept in an air oven at 105ºC for 6 hours and cooled in a dessicator and 
weighed.  Repeated the experiment twice, and taken the average value. The percentage of 
alcohol soluble extractive was calculated by the formula given below. 
Calculation: 
                                                                      Weight of the extract               100 
 Percentage of alcohol soluble extract   =  ------------------------------- x ---------------  x 100  
                                                                      Weight of sample taken           25 
 
RESULTS 
The results of physico chemical properties were represented in table 2. 
  
 
 
Chemical analysis 
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5.3 CHEMICAL ANALYSIS OF  INDHUPPU  BHAVANAI 
The  chemical analysis of Indhuppu Bhavanai was carried out in Bio chemistry Lab, 
National Institute of Siddha. 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of extract 
Dark brown in 
colour 
 
2. 
Test for Slicate 
a. A 500 mg of the sample was 
shaken well with distilled water. 
 
Completely soluble 
Absence of 
Silicate 
3. 
Action of Heat: 
 A 500 mg of the sample was taken in 
a dry test tube and heated gently at 
first and then strong. 
No White fumes 
evolved. 
No brown fumes 
evolved. 
 
Absence of 
Carbonate 
Absence of 
Nitrate. 
 
 
 
4. 
Flame Test: 
  A 500 mg of the sample was made 
into a paste with con. HCl in a watch 
glass and introduced into non-
luminous part of the Bunsen flame. 
 
No bluish green 
flame appeared 
 
Absence  of 
copper 
 
5. 
Ash Test: 
A filter paper was soaked into a 
mixture of extract and dil. cobalt 
nitrate solution and introduced into 
the Bunsen flame and ignited. 
No yellow colour 
flame appeared 
Absence of 
sodium 
 
Preparation of Extract: 
 5 gm of Indhuppu bhavanai (IB) was taken in a 250 ml clean beaker and added 
with 50ml of distilled water. Then it is boiled well for about 10 minutes. Then it is cooled 
and filtered in a 100 ml volumetric flask and made up to 100 ml with distilled water. This 
preparation is used for the qualitative analysis of acidic/basic radicals and chemical 
constituents in it. 
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S. 
No 
EXPERIMENT OBSERVATION INFERENCE 
 I. Test For Acid Radicals   
1. 
Test For Sulphate: 
a.2 ml of the above prepared extract was taken 
in a test tube to this add ed 2 ml of 4% dil 
ammonium oxalate solution 
 
b. 2 ml of the above prepared extract is added 
with 2 ml of diluted HCL is added until the 
effervescence ceases off. Then 2 m of Barium 
Chloride solution is added. 
 
Cloudy appearance 
present 
 
A white precipitate 
insoluble in 
con.HCL was 
obtained. 
Presence  of 
Sulphate 
 
Sulphate was 
confirmed 
2. 
Test For Chloride: 
2 ml of the above prepared extracts was added 
with 2 ml of dil- HCl is added until the 
effervescence ceases off. 
Cloudy appearance 
present. 
Presence of 
Chloride  
 
3. 
Test For Phosphate: 
2 ml of the extract were treated with 2 ml of 
dil.ammonium molybdate solution and 2 ml of 
con.HNo3 
 
No Cloudy yellow 
appearance formed 
 
Absence of 
Phosphate 
4.  
Test For Carbonate: 
2 ml of the extract was treated with 2 ml                                        
diluted magnesium sulphate solution 
No cloudy 
appearance 
Absence of  
carbonate 
5. 
Test For Nitrate: 
1 gm of the extract was heated with copper 
turning and concentrated H2So4 and viewed the 
test tube vertically down. 
 No Brown gas 
was evolved  
 
Absence of 
nitrate 
6. 
Test For Sulphide: 
1 gm of the extract was treated with 2 ml of 
con. HCL 
 No rotten egg 
smelling gas 
evolved 
Absence of 
sulphide 
7. 
Test For Fluoride & Oxalate: 
2 ml of extract was  added with 2 ml of dil. 
Acetic acid and 2 ml dil.calcium chloride 
solution and heated. 
 No cloudy 
appearance. 
Absence of 
fluoride and 
oxalate 
 
8. 
Test For Nitrite: 
3 drops of the extract was placed on a filter 
paper, on that-2 drops of dil.acetic acid and   2  
drops of dil.Benzidine solution is placed. 
 
No characteristic 
changes 
 
Absence of 
nitrite 
34 
 
9. 
Test For Borate: 
2 Pinches (50mg) of the extract was made into 
paste by using dil. sulphuric acid and alcohol 
(95%) and introduced into the blue flame. 
Bluish green 
colour flame not 
appeared 
Absence of 
borate 
 
S.No EXPERIMENT OBSERVATION INFERENCE 
II. Test For Basic Radicals 
1. 
Test For Lead: 
2ml of the extract was added with 2ml of 
dil. potassium iodine solution. 
No Yellow 
precipitate  
appeared 
 
Absence of lead 
 
2. 
Test For Copper: 
a. One pinch (25 mg) of extract was 
made into paste with con. HCl in a 
watch glass and introduced into the non-
luminuous part of the flame. 
No blue colour 
precipitate 
appeared 
Absence of    
copper 
3. 
Test For Aluminium: 
To the 2 ml of extract dil.sodium 
hydroxide was added in 5 drops to 
excess. 
No characteristic 
changes 
Absence of    
Aluminium. 
4. 
Test For Iron: 
a. To the 2 ml of extract add 2 ml of 
dil.ammonium solution 
b. To the 2ml of extract 2ml  thiocyanate 
solution and 2ml  of con HNo3 is added 
Mild  Red colour 
appeared 
Presence of 
Iron 
5. 
Test For Zinc:  
To 2 ml of the extract dil.sodium 
hydroxide solution was added in 5 drops 
to excess and dil.ammonium chloride is 
added.  
No White 
precipitate was 
formed 
Absence of 
Zinc 
6. 
Test For Calcium:  
2 ml of the extract was added with 2 ml 
of 4% dil.ammonium oxalate solution  
Cloudy 
appearance and 
white precipitate 
was obtained 
Presence of 
calcium 
7. 
Test For Magnesium:  
To 2 ml of extract dil.sodium hydroxide 
solution was added in drops to excess. 
No  White 
precipitate was 
obtained 
Absence of 
magnesium 
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8. 
Test For Ammonium: 
To 2 ml of extract 1 ml of Nessler's 
reagent and excess of dil.sodium 
hydroxide solution are added. 
No Brown colour 
appeared 
Absence of 
ammonium 
9. 
Test For Potassium: 
A pinch (25 mg) of extract was treated 
of with 2  ml of dil.sodium nitrite 
solution and then treated with 2 ml of 
dil.cobalt nitrate in 30% dil.glacial 
acetic acid. 
No Yellow 
precipitate was 
obtained 
Absence of 
potassium 
10. 
Test For Sodium: 
2 pinches (50 mg) of the extract is made 
into paste by using HCl and introduced 
into the blue flame of Bunsen burner. 
No yellow colour 
flame evolved 
Absence of 
sodium 
11. 
Test For Mercury:  
 2 ml of the extract was treated with 2 ml 
of dil.sodium hydroxide solution.  
No Yellow 
precipitate  
obtained 
Absence of 
Mercury 
12. 
Test For Arsenic:  
2 ml of the extract was treated with 2 ml 
of dil.sodium hydroxide solution. 
No  Brownish red 
precipitate  
obtained 
Absence of 
arsenic 
 
S.No EXPERIMENT OBSERVATION INFERENCE 
III. Miscellaneous 
1.
  
Test For Starch: 
2 ml of extract was treated with weak 
dil.Iodine solution  
No Blue colour 
developed 
Absence of 
starch 
2.
  
Test For Reducing Sugar: 
5 ml of Benedict's qualitative solution was 
taken in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the 
extract and again boil it for 2 minutes. The 
colour changes are noted. 
No Brick red colour 
developed 
Absence of  
reducing sugar 
3. 
Test For The Alkaloids: 
a) 2 ml of the extract was treated with 2ml 
Yellow colour 
developed 
Presence 
of Alkaloid 
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of dil.potassium lodide solution. 
b)  2 ml of the extract was treated with 2ml 
of dil.picric acid. 
c)  2 ml of the extract was treated with 2ml 
of dil.phosphotungstic acid. 
 
4.
  
Test For Tannic Acid:  
2 ml of extract was treated with 2 ml of 
dil.ferric chloride solution  
Black precipitate  
obtained 
Presence of 
Tannic acid 
5.
  
Test For Unsaturated Compound: 
To the 2 ml of extract 2 ml of dil.Potassium 
permanganate solution is added.  
Potassium 
permanganate was 
not decolourised 
Absence of 
unsaturated 
compound 
6.
  
Test For Amino Acid: 
2 drops of the extract was placed on a filter 
paper and dried well. 20ml of Burette 
reagent is added. 
No violet colour 
Absence of 
amino acid 
7 Test For Type Of Compound: 
2ml of the extract was treated with 2 ml of 
dil.ferric chloride solution. 
No green and red 
colour 
 
 
 
 
 
 
 
No Violet colour 
developed  
 
 
 
 
 
No Blue colour  
developed. 
 
 
Absence of 
quinolepinephr
ine  
pyrocatecho 
Anti pyrine.  
 
 
Aliphatic 
amino acid and 
meconic acid. 
Apomorphine 
salicylate and 
Resorcinol are 
absent. 
 
Morphine 
Phenol cresol 
and 
hydrouinone 
are absent 
 
RESULTS 
The results of acid and basic radicals were showed in table – 3 and table 4 
 
  
 
 
Tlc/hptlc finger print 
Analysis 
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5.4 TLC/HPTLC FINGER PRINT ANALYSIS 
 Thin layer chromatography (TLC) was a chromatographic technique used to 
separate the components of a mixture using a thin stationary phase supported by an inert 
backing. It may be performed on the analytical scale as a means of monitoring the 
progress of a reaction, or on the preparative scale to purify small amounts of a compound. 
 TLC/HPTLC was an analytical tool widely used because of its simplicity, relative 
low cost, high sensitivity, and speed of separation. TLC/HPTLC functions on the same 
principle as all chromatography: a compound will have different affinities for the mobile 
and stationary phases, and this affects the speed at which it migrates. The goal of 
TLC/HPTLC is to obtain well defined, well separated spots. 
TLC and HPTLC Methodology 
 4g of fine powdered extracted with 40ml of  Ethanol soaked for 24 hours. The 
extract was filtered, concentrated and made up to 10 ml in a standard flask. 5µl, 10µl, 15µl 
of the solution were applied on Merck Aluminium plate pre-coated with Silica gel 60 F 254 
of 0.2 mm thickness to a band width of 6 mm using Canag HPTLC system equipped with 
ATS- Iv applicator. The plate was developed in Toluene: Ethyl acetate: Formic 
acid(4:6:0.1). The plate was dried and visualized in UV 254 and UV 366 nm and 
photographs were taken. Before derivitization of the plate it was scanned at UV 254 nm 
and Fingerprint was taken before dipping in Vanillin- Sulphuric acid reagent. 
Retention Factor 
After a separation was complete, individual compounds appear as spots separated 
vertically. Each spot has a retention factor (Rf) which is equal to the distance migrated 
over the total distance covered by the solvent. The Rf formula is, 
Rf  = distance traveled by sample /distance traveled by solvent 
The Rf value can be used to identify compounds due to their uniqueness to each 
compound.  When comparing two different compounds under the same conditions.The 
compound with the larger Rf value was less polar because it does not stick to the 
stationary phase as long as the polar compound, which would have a lower Rf value. 
  
 
 
 
Elemental 
analysis 
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5.5 DETERMINATION OF MICROBIAL LOAD 
Microbial analysis was carried for determination of microbial contamination as per 
procedures of Quality Control Methods for Medicinal plant Materials, WHO Geneva 1998 
Guideline.  
The test included total bacterial count, total fungal count, and identification of 
specified organisms such as Enterobacteriaceae, Escherichia coli, Salmonella spp, 
Staphylococcus aureus and Pseudomonas aeroginosa.  
 
RESULTS 
 
The results of microbial load were represented in table 6. 
 
5.6 HEAVY METAL ANALYSIS – ICP-OES 
 The analysis of heavy metals and trace elements were estimated by using 
inductively coupled plasma optical emission spectrometry (ICP- OES). The Experimental 
Procedure was done at SAIF, IIT Madras, Chennai-36. 
ICP-OESINDUCTIVELY COUPLED PLASMA OPTICAL EMISSIONS  
SPECTROMETRY 
Introduction 
 The element composition of a sample is often an important part of the information 
needed to assess its properties. Hence there is a need for scientific instrumentation like 
ICP-OES which plays a pivotal role in the determination of these elements. ICP-OES is 
widely employed for the estimation of metals and metallolids at trace, minor and major 
concentration. 
Principle  
In this technique, the high temperature plasma source atomizes the sample and 
excites the atoms resulting in emission of photons. The atoms of each element in the 
sample emit specific wavelength of light. The emission spectrum from the plasma is 
dispersed by an optical spectrometer , so that intension of the individual wavelength can 
be measured. 
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 The number of photos emitted is directly proportional to the concentration of the 
element.  The photos may be detected either sequentially or simultaneously.  
Quantitative analysis is achieved by measuring the intensity of these specific 
wavelength and after performing the calibration using known standards.  
Identifying the presence of emission at the wavelength characteristic of the element 
of interest obtaining quantitative information i.e, how much of an element is in sample can 
be accomplished using plots of emission intensity versus concentration called calibration 
curves. 
Perkin Elmer Optima 5300DV was used for standard ICP-OES analysis. 
 
Sample preparation – Microwave Digestion 
 Weight 0.25 g of test sample and transfer into a liner provided with instrument. 
 Slowly add 9ml of Nitric acid or sulphuric acid such that no piece of sample sticks 
on the slide. 
 Mix thoroughly and allow reacting for  few minutes. 
 Place the liner in the vessel jacket. 
 Close the screw cap hand- tight in clockwise direction. 
 Seal the vessel and placed in the rotor fixed in microwave. 
 Set temperature to 180°C for 5 minutes, hold at 180°C  for least 10 minutes.                                                                                                                                                           
Allow the vessels to cool down to a vessel interior temperature below 60°C and to 
a vessel surface temperature (IR) below 50°C before removing the rotor. 
 The digested sample was made upto 100ml  with Millipore water. 
 If visible insoluble particles exist, solution could be filtered through whatmann 
filter paper. 
 Transfer the digested solution into plastic containers and label them properly. 
RESULT 
The analytical results of heavy metals and  trace elements in Indhuppu bhavanai 
using ICP-OES were showed in table 7. 
 
  
 
 
 
PARTICLE SIZE ANALYSIS 
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5.7 SCANNED ELECTRON MICROSCOPY (SEM) 
The partical size of the Indhuppu bhavanai was determined using High resolution 
scanning electron microscopy (HR SEM). The Experimental Procedure was done at SAIF, 
IIT Madras, Chennai-36. 
Experimental procedure : 
              A SEM is essentially a high magnification microscope, which uses a focused 
scanned electron beam to produce images of the sample, both top-down and, with  the 
necessary sample preparation, cross-sections. The primary electron beam interacts with  
the sample in a number of key ways :- 
 Primary electrons generate low energy secondary electrons, which tend to 
emphasize the topographic  nature of the specimen. 
 Primary electrons can be backscattered which produces images with a high degree 
of atomic number (Z) contrast. 
 Ionized atoms can relax by electron shell-to-shell transitions, which lead to either 
X-ray emission or Auger electron ejection.The X-ray emitted are characteristic of 
the elements in the top few  µm of the  sample. 
Resolution   :   1.2 nm gold particle separation on a carbon substrate 
Magnification  :   From a min of 12 X to greater than 1,00,000 X. 
Method : 
          A representative portion of each sample was sprinkled on to a double side carbon 
tape and mounted on aluminium stubs, in order to get a higher quality secondary electron 
image for  SEM examination. 
Sample preparation : 
       Sample preparation can be minimal or elaborate for SEM analysis, depending on  the 
nature of the  samples and the  data required. Minimal preparation includes acquisition of 
a sample that will fit into the SEM chamber and some accommodation to prevent charge 
build-up on electrically insulating samples. 
 The reults were represented in figure 1. 
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6. TOXICOLOGICAL EVALUATION OF INDHUPPU BHAVANAIIN 
RODENTS 
Introduction: 
Safety was a fundamental principle in the provision of traditional medicines and 
herbal products for health care and a critical component of quality control. OECD 
guidelines provide practical and technical guidance for monitoring the safety of traditional 
medicines within pharmacovigilance systems. The safety monitoring of traditional 
medicines was compared and contrasted with that of other medicines, currently undertaken 
in the context of the WHO International Drug perspective. 
Scope of work: 
Monitoring Programme, while there are regulatory and cultural differences in the 
preparation and use of different types of medicines, they are all equally important from a 
pharmacovigilance 
Assurance of safety, quality and efficacy of Indian System of Medicines (ISM) was 
the key issue that needs to be addressed while conducting toxicity studies. It was an 
essential step, which will strengthen the acceptance of Siddha medicines by scientific 
community. Information of toxicity and adverse effects of these formulations were 
lacking. Some of the formulations were proved to be effective in various animal studies 
and many more are yet to be tested.  
Hence, the present study was carried out to evaluate the Preclinical animal toxicity 
studies of  Indhuppu bhavanaiin rodents. 
Plan of work: 
The following studies were carried out on Indhuppu bhavanai. 
 Acute Oral toxicity     - OECD 423 
 Repeated dose 28 days  oral toxicity Study - OECD 407 
 Repeated dose 90 days oral toxicity study  - OECD 408 
 
  
 
 
ACUTE TOXICITY STUDY 
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6.1 ACUTE ORAL TOXICIY STUDY OF INDHUPPU BHAVANAI 
(OECD GUIDELINE – 423) 
Acute oral toxicity-experiment procedure:  
Acute toxicity study was carried out according to the OECD (Organization of 
Economic Co-operation and Development) guidelines 423. Healthy female rats, weighing 
150–200g, were selected and oral administration of the single doses of Indhuppu Bhavanai 
was done aseptically by suspending in 1ml honey. 
Experimental animals: 
Albino rats (wistar rats) of either sex, weighing (150-200 g) were procured from 
animal housing facility, K.K college of Pharmacy, Gerugambakkam, Chennai. All animals 
were placed in a polypropylene cages in a controlled room temperature 24 ̊  C±1̊  C and 
relative humidity of 60-70 % in animal house. The animals were maintained in standard 
pellet diet and water ad libitum. They were acclimatized to laboratory condition for seven 
days before commencement of the experiment. 
All the protocols and the experiments conducted in strict compliance according to 
ethical principles and guidelines provided by committee for the purpose of control and 
Supervision of Experiments on Animals ( IAEC approval no - KKCP/2015/037). Animal 
experimentation protocols are approved by Institutional Animal Ethical Committee. 
Administration of doses:  
Indhuppu Bhavanai was mixed with honey and it was administered as a single oral 
dose by gavage using a feeding needle. Animals were fasted prior to dosing. Following the 
period of fasting, the animals were weighed and then the test substance was administered. 
After the substance has been administered, food was withheld for  further 3 to 4 hours. 
The principle of laboratory animal care was followed.  
Observations were made and recorded systematically and continuously observed as 
per the guideline after substance administration.  
An oral (p.o) dose of 5 mg/kg, 50 mg/kg, 300 mg/kg and 2000 mg/kg was 
administered step by step according to the guidelines. The general behaviors of the rats 
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were continuously monitored for 1 h after dosing, periodically during the first 24 h (with 
special attention given during the first 4 hours and then daily thereafter, for a total of 14 
days. Changes in the normal psychomotor activity and external morphology and their body 
weights were monitored periodically before dosing and the time at which signs of toxicity 
or mortality were recorded. 
 The visual observations included skin changes, morbidity, aggressiveness, 
sensitivity to sound and pain, as well as respiratory movements were recorded. They were 
deprived of food, but not water 12 h prior to the administration of the test substance. 
Finally, the number of survivors were noted after 24 h and these animals were then 
maintained for a further 14 days and observations made daily. The toxicological effect was 
assessed on the basis of mortality. 
 
Test Substance 
 
: 
 
Indhuppu Bhavanai  
Animal Source  : Animal house of King Institute of Preventive 
Medicine 
Animals : Male and Female Wistar Albino Rats  
Age  : More than 8 weeks 
Acclimatization : Seven days prior to dosing. 
Veterinary examination : Prior to and at the end of the acclimatization 
period. 
Identification of animals : By cage number, animal number and individual 
marking on fur. 
Diet : Pelleted feed supplied by Godrej foods Pvt Ltd, 
Bangalore 
Water  : Potable water in polypropylene bottles ad 
libitum. 
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Housing & Environment : The animals were housed in Polypropylene 
cages provided with bedding of husk. 
Housing temperature : Between 20 & 24°C,  
Relative humidity : Between 30% and 70%, 
Dark and light cycle 
Duration of the study                                  
: 
:
Each of 12 hours. 
14 days 
 
Number of animals and dose levels:  
 Three animals were used for each step. The dose level used as the starting dose 
was selected from one of four fixed levels, 5, 50, 300 and 2000 mg/kg body weight. The 
starting dose level was most likely to produce mortality in some of the dosed animals. The 
available information suggests that mortality is likely at the highest starting dose level 
2000mg/kg body weight, so the trial or limit test was conducted. The time interval 
between treatment groups is determined by the onset, duration and severity of toxic signs.  
Observations 
 Animals were observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 
4 hours and daily thereafter, for a total period of 14 days, except where they need to be 
removed from the study and humanely killed for animal welfare reasons or are found dead. 
It should be determined by the toxic reactions, time of onset and length of recovery period 
and may thus be extended when considered necessary. The times at which signs of toxicity 
appear and disappear are important, especially if there is a tendency for toxic signs to be 
delayed.  
All observations were systematically recorded with individual records being 
maintained for each animal. Observations include changes in skin, fur, eyes, mucous 
membranes,  respiratory, circulatory, autonomic and central nervous systems and somato 
motor activity and behavior pattern.  
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Attention was directed to observations of tremors, convulsions, salivation, 
diarrhoea, lethargy, sleep and coma. The principles and criteria summarized in the 
Humane End points Guidance Document taken into consideration. Animals found in a 
moribund condition and animals showing severe pain or enduring signs of severe distress 
was humanely killed. When animals are killed for humane reasons or found dead, the time 
of death should was recorded. From the maximum dose 1\5th or 1\10th of the dose was 
considered as therapeutic dose for further study. 
Results: 
 All data were summarized in table 8. 
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6.2    REPEATED DOSE  28 DAYS ORAL TOXICITY STUDY OF 
INDHUPPU BHAVANAI (OECD GUIDELINE - 407) 
Sub-acute toxicity study was carried out according to OECD 407 and rats were 
divided into 3 groups of 10 animals (5 male and 5 female). Indhuppu Bhavanai with honey   
was administered to rats at the dose of 900mg /kg/day  and 1800 mg/kg/day continuously 
for 28 days. The animals were observed daily for gross behavioural changes and other sign 
of sub acute toxicity. The weight of the each rat was recorded on day 0 and weekly 
throughout the course of the study, food and water consumption per rat was calculated. At 
the end of 28 days they were fasted overnight ,each animal were anaesthetized with diethyl 
ether  and blood samples were collected from the retro-orbital plexus into two tubes: one 
with EDTA for immediate analysis of haematological parameters, the other without any 
anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 minutes to obtain the serum. 
Serum was stored at 20 °C until analyzed for biochemical parameters. 
 
Test Substance : Indhuppu Bhavanai  
Animal Source  : Animal house of King Institute of Preventive Medicine 
Animals : Male and Female Wistar Albino Rats  
Age  : More than 8 weeks 
Acclimatization : Seven days prior to dosing. 
Veterinary examination : Prior to and at the end of the acclimatization period. 
Identification of 
animals 
: By cage number, animal number and individual marking on 
fur. 
Diet : Pelleted feed supplied by Godrej foods Pvt Ltd, Bangalore 
Water  : Portable water in polypropylene bottles ad libitum. 
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Housing& Environment : The animals were housed in Polypropylene cages provided 
with bedding of husk. 
Housing temperature : Between 20 & 24°C,  
Relative humidity : Between 30% and 70%, 
Dark and light cycle 
Duration of study  
: 
: 
Each of 12 hours.  
28 days 
Justification for Dose Selection: 
The results of acute toxicity study in rats indicated that Indhuppu Bhavanaiwas  
non toxic and no behavioral changes were observed up to the dose level of 2000mg/kg 
body weight. The oral route was selected for use because oral route is considered to be a 
proposed therapeutic route. 
Preparation and administration of dose: 
Indhuppu Bhavanaiat two doses level 900mg/kg and 1800 mg/kg respectively were 
prepared. The test substance was prepared every day for 7 days once for 28 days. The 
control animals were administered vehicle only. Administration was by oral (gavage), 
once daily for 28 consecutive days. 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals: 
 The rats randomly divided into three groups in each group consists of 10 rats 
(5male and 5 female) dosing up to 28 days. Animals acclimatization period of 7 days to 
laboratory conditions prior to the initiation of treatment. Each animal was fur marked with 
picric acid. The females were nulliporous and non-pregnant. 
OBSERVATIONS:Experimental animals were kept under observation throughout the 
course of study for the following: 
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i) Body Weight: 
Weight of each rat was recorded on day 0 and at weekly  intervals throughout the 
course of study and at termination to calculate relative organ weights. From the data, 
group mean body weights and percentage of  body weight gain were calculated (table -9 
and table 17 ) 
ii) Food  Consumption:  
The quantity of food consumed by groups consisting of ten animals  for different 
doses was recorded at weekly interval.Food consumed per animal was calculated for 
control and the treated dose groups. (table 11) 
iii) Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
iv) Mortality:  
All animals were observed twice daily for mortality during entire course of study. 
V) Laboratory investigation: 
Following laboratory investigations were carried out on day 29 in animals fasted 
over-night. On 29th day, the animals were fasted for approximately 18 h, then anesthetized 
with ether and blood samples were collected from the retro-orbital plexus into two tubes: 
one with EDTA for immediate analysis of haematological parameters, the other without 
any anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 minutes to obtain the 
serum. Serum was stored at 20 °C until analyzed for biochemical parameters. 
vi) Haematological Investigations:  
Blood samples of control and experimental rats were analyzed for hemoglobin, 
total red blood corpuscles (RBC), white blood corpuscles (WBC) count, Mean corpuscular 
volume (MCV) and packed cell volume (PCV). From the estimated values of RBC count 
(millions/mm3) and PCV (volumes percent), mean corpuscular volume (MCV) was 
calculated.  
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vii) Biochemical Investigations:  
Serum and Urine was used for the estimation of biochemical parameters. Samples 
of control and experimental rats were analyzed for protein, bilirubin, urea, uric acid, 
creatinine, triglyceride, cholesterol and glucose levels by using standard methods. 
Activities of glutamate oxaloacetate transaminase/ Aspartate aminotransferase 
(GOT/AST), glutamate pyruvate transaminase/ Alanine amino transferase (GPT/ALT) and 
alkaline phosphatase were estimated as per the colorimetric procedure.  
viii) Necropsy:  
All the animals were sacrificed on day 29. Necropsy of all animals were carried out 
and the weights of the organs including liver, kidneys, adrenals, spleen, brain, heart, 
stomach, uterus and testes/ovaries were recorded. The relative organ weight of each 
animal was then calculated as follows; 
     Absolute organ weight (g) 
Relative organ weight = ____________________________________________ ×100 
    Body weight of rats on sacrifice day (g) 
ix) Histopathology:   
Histopathological investigation of the vital organs were done. The organ piece (3-
5µm thick) of the highest dose level of 4500mg /kg were preserved and were fixed in 10% 
formalin for 24 h and washed in running water for 24 h. Samples were dehydrated in an 
auto technicon and then cleared in benzene to remove absolute alcohol.  Embedding was 
done by passing the cleared samples through three cups containing molten paraffin at 
50°C and then in a cubical block of paraffin made by the “L” moulds. It was followed by 
microtome and the slides were stained with Haematoxylin-eosin. The organs included  
heart, kidneys, liver, spleen, stomach of the animals were preserved they were subjected to 
histopathological examination. 
Statistical analysis: Findings such as clinical signs of intoxication, body weight changes, 
food consumption, hematology and blood chemistry were subjected to One-way Anova  
Followed by Dunnet’s test using a computer software programme. (Graph Pad Prism 5.0). 
All data were summarized in tabular form(Table 9 – 17) 
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6.3   REPEATED DOSE 90 DAYS ORAL TOXICITY STUDY OF 
INDHUPPU BHAVANAI (OECD GUIDELINE - 408) 
Test Substance :   INDHUPPU BHAVANAI 
Animal Source :   Animal house of King Institute of Preventive Medicine  
Animals : Wister Albino Rats (Male -3, and Female-3) 
Age : 6-8 weeks 
Body Weight               :  150-200gm. 
Acclimatization :   Seven days prior to dosing. 
Veterinary examination :    Prior and at the end of the acclimatization period. 
Identification of animals      :    By cage number, animal number   and    individual     
     marking  by  using Picric acid. 
Diet :    Pellet feed supplied by Sai meera foods Pvt Ltd,        
  Bangalore 
Water : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
  provided with bedding of husk. 
Housing temperature : between 22ºC + 3ºC.   
Relative humidity :  between 30% and 70%, 
Air changes  : 10 to 15 per hour  
Dark and light cycle  : 12:12 hours. 
Duration of the study :  90 Days. 
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METHODOLOGY 
Randomization, Numbering and Grouping of Animals: 
24 Wistar Albino Rats (12M + 12F) were selected and divided into 4 groups. Each 
group consist of 6 animals (Male -3, and Female-3) IAEC approval no NIS/IAEC –
I/2016/05. Ist group treated as a control and other three group were treated with test drug 
(low, mid, high) for  90 days. Animals were allowed acclimatization period of 7 days to 
laboratory conditions prior to the initiation of treatment. Each animal was marked with 
picric acid. The females were nulliparous and non-pregnant. 
Justification for Dose Selection: 
         As per OECD guideline three dose levels were selected for the study. They were low 
dose (X), mid dose dose (5X), high dose (10X). X is calculated by multiplying the 
therapeutic dose (5gm) and the body surface area of the rat (0.018). i.e X dose is 180 
mg/kg, 5X dose is 900mg/kg and 10 X 1800 mg/kg  of animal. 
Preparation and Administration of Dose: 
Indhuppu bhavanai was suspended in Honey with distilled water to obtain concentrations 
of 200mg/ml. It was administered to animals at the dose levels of X, 5X, 10X. The test 
substance suspensions were freshly prepared every two days once for 90 days. The control 
animals were administered vehicle only. The drug was administered orally by using oral 
gavage once daily for 90 consecutive days. 
OBSERVATIONS: 
Body Weight: 
 Weight of each rat was recorded on day 0, at weekly intervals throughout the  
course of study (Table 18) 
Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
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 Mortality: 
All animals were observed twice daily for mortality during entire course of   study. 
Laboratory Investigations: 
Following laboratory investigations were carried out on day 91 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Haematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
Haematological Investigations: 
Haematological parameters were determined using Haematology analyzer. 
Biochemical Investigations:  
 Biochemical parameters were determined using auto-analyzer. 
Histopathology:  
Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group than 
the low, then the mid dose group will also be examined. Organs will be collected from all 
animals and preserved in 10% buffered neutral formalin for 24 h and washed in running 
water for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in an auto 
technicon and then cleared in benzene to remove absolute alcohol. Embedding was done 
by passing the cleared samples through three cups containing molten paraffin at 50°C and 
then in a cubical block of paraffin made by the “L” moulds. It was followed by microtome 
and the slides were stained with Haematoxylin-eosin. 
Statistical analysis: 
Findings such as clinical signs of intoxication, body weight changes, haematology and 
blood chemistry were subjected to One-way ANOVA followed by dunnet’t test using a 
computer software programme -INSTAT-V3 version. All data were summarized in tabular 
form(Table 18–23 ). 
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7.1 ANTIULCER ACTIVITY OF INDHUPPU BHAVANAION 
WISTAR ALBINO RATS 
Aim: 
To evaluate the antiulcer activity of Indhuppu bhavanai in Wistar albino rats by 
Aspirin induced  ulcer model. 
Selection of Experimental animals: 
 Healthy Wistar albino rats of either sex weighing (150-200 gms ) were used for 
this study. The animals were obtained from animal house, K.K college of pharmacy, 
Gerugambakkam, Chennai. Animals were housed at a temperature of 24±2 ͦ  c and 
relative humidity of 30-70% at 12 :12 light, day cycle was followed. All the animals were 
allowed to free access to water and fed with standard commercial pellet. All the 
experimental procedures and protocols used in this study were reviewed by (IAEC) 
Institutional Animal Ethics Committee (IAEC approval No KKCP/2015/037) of K.K 
college of Pharmacy and were in accordance with the guidelines of the IAEC. 
Aspirin Induced Gastric Ulcers 
Principle: 
Aspirin was a NSAID which inhibit the synthesis of prostaglandins. Prostaglandins 
protect the gastric mucosa by producing leukotrienes and bicarbonate ions. Aspirin also 
inhibit the gastric peroxidase and may increase mucosal hydrogen peroxide and hydroxyl 
ions level to cause oxidative mucosal damage. 
Procedure: 
Albino rats of either sex weighing between 150-250 gms were divided into five 
groups and each consisting of six rats. 
Group I :   Control (2ml/kg p.o.) 
Group II :   Negative control received only Aspirin (500mg/kg) 
Group III :   Standard drug Ranitidine(20mg/kg)+ Aspirin (500 mg/kg) 
Group IV :   Received Indhuppu bhavanai 200mg/kg + Aspirin (500 mg/kg)  
Group V :   Received  Indhuppu bhavanai 400mg/kg + Aspirin (500 mg/kg) 
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The animals were fasted for 24 hours. The test drug in varying concentration based on the 
design of the experiment is administered orally 30 minute prior to aspirin at dose of 500 
mg/kg. 4hours later the rats were scarified by using anaesthetic ether and their stomaches 
were dissected and they were opened along the greater curvature for the determination of 
gastric lesions. Ulcer index was calculated by  the number of ulcers per animal and 
severity scored by observing the ulcers microscopically with the help of 10X lens. 
 
Evaluation of parameters: 
Effect of Free Acidity and Total Acidity : 
The free acidity and total acidity was determined based on the titre values. One ml 
of gastric juice was pipetted into 100 ml of conical flask and titrates with 0.01N NaOH 
using topers reagent as an indicator (It is Dimethyl –amino-azo-benzene with 
phenolphthalein and used for the detection  and estimation of hydrochloric acid and total 
acidity in gastric fluids) titrate to end point, when the solution turns to orange colour, note 
the volume of NaOH which corresponds to free acidity. Titrate further till the solution 
regains its pink colour. Note the volume of NaOH which corresponds to the free acidity. 
Acidity (mEq/L/100g) can be expressed as 
 
     Volume of NaOH X Normality of NaOH 
Acidity= ______________________________________ ×100 
     0.1 
Ulcer index : 
  The ulcer index was calculated by taking the mean ulcer score of each groups. 
Then the mean ulcer score graph was plotted with groups on x-axis and ulcer index on y-
axis. The histograms of different groups were then interpolated by comparing the ulcer 
index of groups  
 
Collection of Gastric Juice 
The stomach was excised carefully opened along the greater curvature and the 
gastric contents were removed.  The gastric contents were collected in plain tubes and 
centrifuged at 3000 rpm for 5 min, the volume of the supernatant was expressed as ml /100 
55 
 
gm body weight. The mucosa was flushed with saline and observed for gastric lesions 
using a dissecting microscope, ulcer score was determined. 
 
Ulcer Scoring 
 After sacrificing the rat, stomach was removed and opened along the greater 
curvature, and washed it slowly under running tap water.  Put it on the glass slide and 
observe under 10X magnification for ulcer.  Score the ulcers as below. 
 
0 =  normal coloured stomach 
0.5 =  red colouration 
1 =  spot ulcers 
1.5 =  haemorrhagic streaks 
2  =  Ulcers ≥ 3 but ≤ 5 
3 = Ulcers >5 
Mean ulcer score for each animal is expressed as Ulcer Index. 
 
The results of anti-ulcer activity by Aspirin induced ulcer model showed in table -  26 
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7.2  ANTI- INFLAMMMATORY ACTIVITY OF INDHUPPU 
BHAVANAI ON WISTAR ALBINO RATS 
 
AIM: 
To evaluate the anti - inflammatory activity of Indhuppu bhavanai in Wistar albino 
rats by Cotton pellet granuloma method. 
 Selection of Experimental animals: 
The experimental protocol was submitted and approved by institutional Ethical 
Committee, (IAEC approval No KKCP/2015/037). Wistar albino rats (150- 180 gm) of 
approximate same age were employed in this investigation. The animals were obtained 
from animal house, K.K college of pharmacy, gerugambakkam, Chennai. Animals were 
housed at a temperature of 24±2
o
 C and relative humidity of 30-70% at 12 :12 light, day 
cycle was followed. All the animals were allowed to free access to water and fed with 
standard commercial pellet.  
 
Experimental Design for Cotton pellet granuloma  model 
 The animals were divided into four groups each group consists of 6 animals. 
 
Group-I :   Control - Vehicle control received distilled water  (dose: 10 ml/kg). 
Group-II :   Standard drug - Animals treated with Dexamethasone (dose: 0.5 mg/kg). 
Group-III :  Animals treated with Indhuppu Bhavanai ( 200 mg/kg). 
Group-IV :  Animals treated with Indhuppu Bhavanai ( 400 mg/kg) 
Experimental procedure 
Inflammation was induced by cotton pellet granuloma model. This method was  
carried out by using sterilized cotton pellet implantation method in rats. Under light ether 
anesthesia by using blunted forceps, subcutaneous tunnel was made and sterilized cotton 
pellets (10 ± 1 mg) were implanted in the axilla and groin region of the rat. After 
recovering from anaesthesia, animals were treated orally with vehicle control (Distilled 
water 10 ml / kg), Dexamethasone 0.5 mg/kg, low dose (200mg/kg) and high dose 
(400mg/kg) of Indhuppu Bhavanai for consecutive 7 days, once per day. They were 
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sacrificed on day 8th by cervical dislocation and the pellets were removed and 
immediately the wet weight was taken, freed from extraneous tissue and dried at 600C for 
24 hrs. The percentage inhibition of  wet weight and dry weight of the granuloma were 
calculated and compared. 
          Control - Treated 
Percentage inhibition (%)   = ______________________ ×100 
        Control 
The results of anti- inflammatory activity by Cotton pellet granuloma method 
showed in table -  27. 
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7.3 ANALGESIC ACTIVITY OF INDHUPPU BHAVANAI ON SWISS 
ALBINO MICE 
 
AIM: 
To evaluate the Analgesic activity of  Indhuppu bhavanai in Wistar albino rats by 
Eddy’s Hot plate method. 
 Selection of Experimental animals: 
 The experimental protocol was submitted and approved by institutional Ethical 
Committee, (IAEC approval No KKCP/2015/037). Swiss albino mice (20-25 gm) of 
approximate same age were employed in this investigation. The animals were obtained 
from animal house, K.K College of Pharmacy, Gerugambakkam, Chennai. Animals were 
housed at a temperature of 24±2c and relative humidity of 30-70% at 12 :12 light, day 
cycle was followed. All the animals were allowed to free access to water and fed with 
standard commercial pellet.  
Evaluation of Analgesic activity 
               Pain is the part of a defensive reaction against dysfunction of an organ or 
imbalance in its functions against potentially dangerous stimulus. The ascending pathway 
of pain includes the contra lateral spinothalamic tract, lateral pons, mid brain to thalamus 
and ultimately through the somatosensory cortex of the brain that determines the locations, 
intensity and depth of pain 
Eddy’s Hot plate method: 
Principle:  
 Painful reactions can be produced in experimental animals by applying 
noxious stimuli such as thermal – using radiant heat as a source of pain, chemical  – using 
irritants such as acetic acid and bradykinin and physical pressure  – using tail compression.  
The hot plate test was a test of the pain response in animals. It was used in basic 
pain research and in testing the effectiveness of analgesics by observing the reaction to 
pain caused by heat. 
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 They used a behavioral model of nociception where behaviors such as jumping and 
hind paw-licking are elicited following a noxious thermal stimulus. Licking was a rapid 
response to painful thermal stimuli that was a direct indicator of nociceptive threshold. 
Jumping represents a more elaborated response, with a latency and encompasses an 
emotional component of escaping. 
Animals 
Mice 20-25 g were grouped in four groups, six animals in each group. 
Grouping: 
Group I : Control - distilled water (10ml/kg, p.o.),   
Group II  : Standard drug - Pentazocine (5mg/kg, p.o.)  
Group III : Indhuppu Bhavannai (200mg/kg)  
Group IV : Indhuppu Bhavannai (400mg/kg) 
 
Equipment: 
 
 Eddy’s Hot plate 
 
Procedure: 
Animals were weighed and placed on the hot plate. Temperature of the hot plate 
was maintained at 55±1
o
 C. Jumping response was seen. The time period (latency period), 
from when the animals were placed and until the responses occurred, were recorded using 
a stopwatch. To avoid tissue damage of the animals 10 seconds was kept as a cut off time.  
The time obtained was considered the basal / normal reaction time in all the untreated 
groups of animals. Increase in the basal reaction time was the index of analgesia.  
All the animals were screened initially at least three times in this way and the 
animals showing a large range of variation in the basal reaction time were excluded from 
the study. A final reading of the basal reaction time was recorded for the included animals. 
After selecting the animals, the drugs were administered to all the groups at the stipulated 
doses. The reaction times of the animals were then noted at  0, 30 , 60 ,90 ,120 and 150 
mins  interval after drug administration. 
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Statistical analysis 
Results were expressed as mean ± SEM and analyzed using Graph Pad Prism 
software. One way analysis of variance (ANOVA) test was applied.  
P value less than 0.05 (P<0.05) was considered as statistically significant. 
The results of analgesic activity by Eddy’s Hot plate method was represented in table 28. 
 
  
 
 
Results 
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8 RESULTS 
5.1 ORGANOLEPTIC CHARACTER* 
Table:1.  Organoleptic characters of Indhuppu bhavanai  
      Colour Dark Brown 
      Odour Characteristic odour 
      Taste Characteristic taste 
      Texture Fine powder 
 
5.2 PHYSICOCHEMICAL ANALYSIS* 
Table 2 Physicochemical properties of Indhuppu bhavanai 
S.NO Parameters Results 
1. pH at 10% of aqueous solution 3.91 
2. Total Ash 62.12% 
3. Water soluble extractive 45.52% 
4. Acid insoluble ash 0.1% 
5. Loss on drying @ 105
o 
C(w/w) 6.04% 
6 Alcohol soluble extractive 8.92 
 
 
*The experimental procedure was analyzed at Captain Srinivasamurti Reseach 
Institute for Ayurveda and Siddha Drug Development, Arumbakkam, Ch-106. 
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5.3 CHEMICAL ANALYSIS * 
Table 3:   Results of acid radicals studies of Indhuppu bhavanai 
S.NO Parameter Observation Result 
1 Test for Sulphate 
Cloudy appearance 
present 
Positive 
2 Test for Chloride 
Cloudy appearance 
present 
Positive 
3 Test For Phosphate  Negative 
4 Test For Carbonate  Negative 
5 Test For Nitrate - Negative 
6 Test for Sulphide - Negative 
7 Test For Fluride &oxalate - Negative 
8 Test For Nitrite - Negative 
9 Test For Borax - Negative 
 
Interpretation 
The acidic radicals test shows the presence of Chloride and sulphate. 
 
 
*The  chemical analysis was carried out in Bio chemistry Lab, NIS, Ch – 47 
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Table: 4    Results of basic radicals studies of Indhuppu bhavanai* 
S.NO Parameter Observation Result 
1 Test for Lead - Negative 
2 Test for Copper - Negative 
3 Test For Aluminium - Negative 
4 Test For Iron Blood red colour Positive 
5 Test For Zinc - Negative 
6 Test for Calcium 
Cloudy appearance and white 
precipitate is obtained 
Positive 
7 Test For Magnesium - Negative 
8 Test For Ammonium - Negative 
9 Test For Potassium - Negative 
10 Test For Sodium - Negative 
11 Test For Mercury - Negative 
12 Test For Arsenic - Negative 
 
Interpretation 
The basic radical test shows the presence of Iron, Calcium and absence of heavy metals 
such as lead, arsenic and mercury. 
*The  chemical analysis was carried out in Bio chemistry Lab, National Institute Of 
Siddha, Ch- 47 
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5.4 TLC  and HPTLC analysis of Indhuppu bhavanai * 
The procedure recommended for the analysis of TLC  and  HPTLC analysis as per Wagner 
H and Bladt S, 1996 
 
Table 5:  
S.No 
254nm 366nm 
Dipped in Vanillin- 
Sulphuric Acid 
Colour Rf Colour Rf Colour Rf 
1 Green 0.08 Red 0.54 Grey 0.08 
2 Green 0.34 Blue 0.86 Grey 0.23 
3 Green 0.97 Blue 0.91 Red orange 0.27 
4   Red 0.98 Grey 0.47 
5     Grey 0.81 
6     Grey 0.86 
7     Brown 0.97 
 
 
 
 
 
 
 
*The experimental procedure was analyzed at Captain Srinivasamurti Reseach 
Institute for Ayurveda and Siddha Drug Development, Arumbakkam, Ch-106. 
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TLC Photo documentation of DTL 1510354 Sample (Ethanol extract) 
254nm       366nm 
  
    After dipping vanillin sulphuric acid 
 
 Solvent system : Toluene: Ethyl acetate: formic acid (4:6:0.1) 
Track 1-5 µl; Track 2-10µl; Track 3-15µl 
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HPTLC finger print profile of DTL 1510354 sample (Ethanol extract)-5µl -254nm 
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HPTLC finger print profile of DTL 1510354 sample (Ethanol extract)-10µl-254nm 
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HPTLC finger print profile of DTL 1510354 sample (Ethanol extract)- 15µl -254nm 
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Table : 6 Screening for Micro – organisms in Indhuppu bhavanai * 
 
S.No Parameters Results 
Permissible Limit for 
Internal use 
1 Total  Bacterial Count (TBC) <10
3
cfu/g 10
5 
CFU/g 
2 Total  Fungal  Count (TBC) <10
3
cfu/g 10
3 
CFU/g 
3 Enterobacteriaceae Absent 10
3 
CFU/g 
4 Escherichia coli Absent 10CFU/g 
5 Salmonella spp Absent Absent 
6 Staphylococcus aureus Absent Absent 
 
RESULTS 
 The microbial load analysis confirms Indhuppu bhavani was free from micro- 
organisms and fungal infections. 
 
 
 
 
 
*The experimental procedure was analyzed at Captain Srinivasamurti Reseach 
Institute for Ayurveda and Siddha Drug Development, Arumbakkam, Ch-106. 
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5.6 ELEMENTAL ANALYSIS 
Table 7 ICP-OES study results of Indhuppu bhavanai 
S.No Elements Wavelength in  nm mg/L 
1 Arsenic As188.979 BDL 
2 Calcium Ca 315.807 12.460 
3 Cadmium Cd 228.802 BDL 
4 Copper Cu 327.393 BDL 
5 Mercury Hg 253.652 BDL 
6 Potassium K 766.491 13.801 
7 Sodium Na 589.592 124.310 
8 Nickel Ni 231.604 BDL 
9 Lead 220.353 BDL 
10 Phosphorus P 213.617 06.741 
 
BDL - Below Detection Limit, ppm – Parts per million 
 
Table 7 shows the quantitative analysis of the elements present in Indhuppu bhavanai. 
The heavy metals were found to be within normal limits. The presence of other elements 
shows the therapeutic value of Indhuppu bhavanai. 
 
________________________________________________________________________ 
* The Experimental Procedure was done at SAIF, IIT Madras, Chennai-36. 
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5.7 PARTICLE SIZE ANALYSIS * 
SCANNED ELECTRON MICROSCOPY 
Determination Of Particle size of Indhuppu bhavanai 
Figure 1 
 
 
The picture shows that the particles are stabilize, have irregular morphology and 
distributed in near nano range. Indhuppu bhavanai has particle size of  0.06 to 0.15µ. 
 
 
 
 
 
 
*The Experimental Procedure was done at SAIF, IIT Madras, Chennai-36. 
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6 TOXICITY STUDY ON INDHUPPU BHAVANAI 
6.1 Acute oral toxicity study of Indhuppu bhavanai * 
Table 8: Dose finding experiment and its behavioural Signs of Toxicity in wistar 
albino rats  
No 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 5 + - - - - + - - - - - - - - - - - - - - 
2 50 + - - - - + - - - - - - - - - - - - - - 
3 300 + - - - - + - - - - - - - - - - - - - - 
4 2000 + - - - - + - - - - - - - - - - - - - - 
 
1.Alertness 2.Aggressiveness 3.Pile erection 4.Grooming 5.Gripping 6.Touch Response 
7.Decreased Motor activity 8.Tremors 9.Convulsions 10.Muscle Spasm 11.catatonia 
12.Muscle relaxant 13.Hypnosis 14.Analgesia 15.Lacrimation 16.Exophthalmos 
17.Diarrhoea 18. Writhing 19.Respiration 20.Mortality 
+ Presence of Activity 
-Absence of Activity 
RESULT 
All the data were summarized in the form of table (8) revealed no abnormal signs 
and behavioral changes in rats upto the dose level of 2000 mg/kg body weight 
administered orally 
 
 
* Acute oral toxicity was done at K.K college of Pharmacy, Gerugambakkam, Chennai 
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Table 9 : Body wt gram of wistar albino rats exposed to Indhuppu Bhavanai for 28 
days 
Dose 
(mg/kg/day) 
Days 
0 7 14 21 28 
Control 157±4.37 157.42±1.17 156.92±1.21 157.36±1.41 158.01±1.03 
MD dose 154.13±0.82 154.72±0.55 155.24±0.98 156.1±1.17 159.12±0.52 
HD dose 155.8±1.03 156.12±0.75 156.69±0.89 157.22±0.75 158.11±1.52 
Values are mean of 10 animals ± S.E.M (Dunnet’s test) *p<0.05 ;**p<0.01.N=10 
 Table 10 :Water (ml/day) intake of albino rats exposed to Indhuppu Bhavanai for 28 
days 
Dose(mg/kg/day) 
Days 
1 7 14 21 28 
Control 32.0±0.92 33.36±0.23 33.23±0.23 33.18±0.16 33.64±0.38 
MD dose 35.83±0.49 34.5±1.52 34.33±1.51 35.5±1.05 35.83±1.72 
HD dose 34.72±1.51 35.19±1.79 36.17±1.51 36.42±1.33 36.59±1.52 
 
Values are mean of 10 animals ± S.E.M (Dunnet’s test) *p<0.05 ;**p<0.01.N=10 
Table 11: Food (g/day) intake of albino rats exposed to Indhuppu Bhavanai  for 28 
days 
Dose 
(mg/kg/day) 
Days (gms/rats) 
1 7 14 21 28 
Control 33.5±0.84 34.72±1.17 35±0.75 35.32±1.97 35.86±1.37 
MD dose 35.82±0.82 38.16±0.75 38.02±0.98 39.83±1.60 39.33±1.21 
HD dose 34.75±2.02 37.13±1.33 37.93±1.10 39.33±1.51 39.83±1.17 
 
Values are mean of 10 animals ± S.E.M (Dunnet’s test)* p<0.05 ;**p<0.01.N=10 
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Table 12: Hematological parameters after 28days treatment with Indhuppu Bhavanai 
in rats 
Parameters Control MD dose HD dose 
Total RBC(10
6
mm
-3
) 9.08±0.03 9.09±0.02 9.11±0.02 
HB (g/dl) 14.40±0.18 14.60±0.32 14.63±0.29 
Leukocyte(10
3
mm
-3
)  12.33±0.22 12.13±0.12 12.16±0.15 
Platelets lakhs/µl 315.81±.4.43 320.83±0.98 325.30±3.18 
MCV%ft 51.01±0.76 52.62±1.22 52.21±1.18 
PCV% 39.13±0.12 39.24±0.37 39.45±1.22 
 
Values are mean of a 10 animals ± S.E.M (Dunnet’s test)* p<0.05 ;**p<0.01.N=10 
Chart 1:  The mean value of HB, Total RBC  of control and treated groups of wistar 
albino rats exposed to Indhuppu bhavanai for 28 days 
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Chart 2 : The mean value of Platelet of control and treated groups of wistar albino 
rats exposed to Indhuppu bhavanai for 28 days 
 
Chart 3: The mean value of Leucocyte, MCV and PCV of control and treated groups 
of wistar albino rats exposed to Indhuppu bhavanai for 28 days 
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Table 13 : Effect of treatment with Indhuppu Bhavanai  on biochemical parameters 
Dose(mg/kg) Control MD dose HD dose 
Total 
Bilirubin(mg/dl) 
0.3013±0.01 0.3015±0.01 0.27±0.01 
Bilirubin 
direct(mg/dl) 
0.2±0.02 0.16±0.02 0.18±0.02 
Bilirubin 
indirect(mg/dl) 
0.1±0.02 0.14±0.01 0.1±0.01 
ALP(IU/L) 80.0±0.89 82.0±1.17 83.0±1.51 
SGOT(IU/L) 52.16±0.75 54.42±0.84 54.07±0.63 
SGPT(IU/L) 25.01±0.16 23.41±0.29 24.26±1.60 
Total protein(g/dl) 6.24±0.10 6.30±0.10 6.24±0.10 
Albumin(g/dl) 3.04±0.04 3.04±0.04 3.06±0.04 
Globulin(g/dl) 5.023±0.03 5.29±0.01 5.15±0.04 
Values are mean of 10 animals ± S.E.M (Dunnet’s test)* p<0.05 ;**p<0.01.N=10 
Chart 4 The mean value of Total Bilirubin, Direct bilirubin and indirect bilirubin of 
control and treated groups of wistar albino rats exposed to Indhuppu bhavanai 
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Chart 5 The mean value of ALP,SGOT and SGPT of control and treated groups of 
wistar albino rats exposed to Indhuppu bhavanai for 28 days 
 
Chart 6  The mean value of Albumin,globulin and total protein of control and 
treated groups of wistar albino rats exposed to Indhuppu bhavanai for 28 days 
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Table 14 Effect of Indhuppu bhavanai on Renal function test 
Dose (mg/kg) Control MD dose HD dose 
Urea(mg/dl) 17.42±0.10 17.23±0.11 17.71±0.11 
Creatinine(mg/dl) 0.67±0.01 0.70±0.02 0.72±0.02 
Uric acid(mg/dl) 1.4±0.02 1.4±0.02 1.47±0.04 
Na m.mol 145.91±0.55 146.50±0.55 146.66±0.52 
K m.mol 6.11±0.01 6.16±0.02 6.46±0.20 
Cl m.mol 98.20±0.10 100.20±0.10 99.68±1.10 
 
Values are mean of 10 animals ± S.E.M (Dunnet’s test) *p<0.05 ;**p<0.01.N=10 
 
Chart 7 The mean value of Urea, Creatinineand uric acid  of control and treated 
groups of wistar albino rats exposed to Indhuppu bhavanai for 28  days 
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Chart 8  The mean value of sodium, potassium and chloride levels of control and 
treated groups of wistar albino rats exposed to Indhuppu bhavanaifor 28 days 
 
Table 15: Lipid Profile 
Parameters Control MD dose HD dose 
Total cholesterol (mg/kg) 34.86±0.39 34.50±0.38 35.01±.0.35 
HDL(mg/dl) 12.05±0.02 12.2±0.05 12.17±0.09 
LDL(mg/dl) 35.83±0.42 36.73±0.36 37.18±0.70 
VLDL (mg/dl) 15.80±0.03 15.81±0.02 15.75±0.04 
Triglycerides(mg/kg) 78.33±0.52 79.0±1.26 81 ±0.82 
TC/HDL ratio (g/dl) 3.41±0.04 3.36±0.04 3.22±0.03 
Blood glucose (mg/dl) 121.90±0.66 121.84±0.82 121.98±0.36 
 
Values are mean of 10 animals ± S.E.M (Dunnet’s test) *p<0.05 ;**p<0.01.N=10 
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Chart 9  The mean value of Sr.TC, Sr.TG, HDL,LDL,VLDL of control and treated 
groups of wistar albino rats exposed to Indhuppu bhavanai for 28 days 
 
Chart 10The mean value of Blood sugar of control and treated groups of wistar 
albino rats exposed Indhuppu bhavanai for 28 days 
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Table 16: Urine Analysis of 28 Days Repeated oral toxicity study of Indhuppu 
bhavanai in wistar albino rats 
Parameters Control MD dose HD dose 
Transparency Clear Slightly turbid Slightly turbid 
Specific gravity 1.010 1.010 1.010 
PH >7.2 >7.2 >7.2 
Protein Nil Nil Nil 
Glucose Nil Nil Nil 
Bilirubin -ve -ve -ve 
Ketones -ve -ve -ve 
Blood  Absent Absent Absent 
Urobilinogen Normal normal normal 
Pus cells 0-cells/HPF 0-cells/HPF 1-cells/HPF 
RBC Nil Nil 1-cells/HPF 
Epithelial cells Nil 1-cells/HPF Nil 
Crystals Nil Nil Nil 
Casts Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen 
Colour Yellow Yellow Yellow 
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Table 17:Effect of oral administration of Indhuppu Bhavanai   on organ weight 
Dose (mg/kg) Control MD dose HD dose 
Liver(g) 4.39±0.07 4.51±0.01 4.54±0.03 
Heart (g) 0.39±0.04 0.39±0.03 0.39±0.02 
Lung(g) 1.30±0.24 1.30±0.20 1.30±0.20 
Spleen (g) 0.48±0.16 0.50±0.18 0.50±0.22 
Ovary (g) 1.47±0.01 1.49±0.02 1.49±0.02 
Testes(g) 1.20±0.10 1.22±0.22 1.22±0.28 
Brain(g) 1.34±0.02 1.36±0.02 1.37±0.01 
Kidney(g) 0.60±0.04 0.62±0.04 0.62±0.04 
Stomach(g) 1.36±0.03 1.38±0.02 1.38±0.02 
 
Values are mean of 10 animals ± S.E.M (Dunnet’s test) *p<0.05 ;**p<0.01.N=10 
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HISTOPATHOLOGICAL OF VARIOUS ORGANS AFTER THE REPEATED 
DOSE 28 DAY ORAL TOXICITY STUDY OF INDHUPPU BHAVANAI IN 
WISTAR ALBINO RATS 
Heart  
 
 
 
  
                     
a.Control        b. Mid dose group 
 
 
 
 
 
    c.High dose group 
Observations 
a.Section of the heart  showed normal muscle fibres with acidophilic cytoplasm and 
centrally located nuclei. 
b. Section of the heart  showed normal muscle fibres with acidophilic cytoplasm and 
centrally located nuclei 
c. Section of the heart  showed normal muscle fibres with acidophilic cytoplasm and 
centrally located nuclei  
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Kidney 
    
a.Control              b. Mid dose 
 
 
                                                C. High dose 
Observations 
a.Section of kidney from control animals  showed normal  size of glomeruli with normal 
tubules. 
b.Section of kidney showed normal glomeruli and there is no necrosis of tubular 
epithelium in the kidney. 
c. Section of kidney showed normal glomeruli and there is no necrosis of tubular 
epithelium in the kidney 
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Liver 
  
a.Control          b.   Mid dose 
 
 
 
 
 
    c.High dose 
Observations 
a. Section of liver from control animals showed no degeneration of hepatocytes, focal 
steatosis,congestion of central vein and inflammation of portal tract . 
b. Section of liver showed no degeneration of hepatocytes, focal steatosis, congestion of 
central vein and inflammation of portal tract  
c. Section of liver showed no degeneration of hepatocytes, focal steatosis,congestion of 
central vein and inflammation of portal tract 
 
 
 
 
86 
 
Spleen 
    
 
a. Control        b. Mid dose     
 
 
c. High dose 
Observations 
a. Section of spleen from control animal showed normal granular hemosiderin pigment 
predominantly within macrophages in the red pulp. 
b. Section of spleen showed normal granular hemosiderin pigment predominantly within 
macrophages in the red pulp with normal structure. 
c. Section of spleen showed normal granular hemosiderin pigment predominantly within 
macrophages in the red pulp with normal structure 
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Stomach 
 
 
a.   Control                                                     b. Mid dose 
 
 
 
   
 
 
                                                         C. High dose 
Observation 
a. Section of stomach shows gastric mucosa lined bytall columnar cells that detected no 
abnormality. 
b. Section of stomach shows gastric mucosa lined bytall columnar cells that detected no 
abnormality 
c. Section of stomach shows gastric mucosa lined bytall columnar cells that detected no 
abnormality. 
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RESULTS OF REPEATED DOSE 28 DAYS ORAL TOXICITY STUDY 
Repeated dose 28 days oral toxicity of Indhuppu bhavanai on rats were 
conducted. All animals from the treated dose survived throughout the dosing period of 28 
days. Various parameters were studied and the interpretation of the study result was  
discussed below. 
Clinical signs: No abnormal behavioural signs were observed during the study period. 
Mortality 
 The test drug “ Indhuppu bhavanai” did not cause any mortality in mid and high 
dose levels and were considered as safe dose levels.  
Body weight: 
The result of the body weight of rats exposed to control and the trial drug of 
different dose groups exhibited over all mild weight gain throughout the dosing period of 
28 days. The quantity of food taken by the animals from different dose groups and the 
control is comparably normal. 
Haematological investigation interpretation 
The haematological investigation results of the rats conducted on 28th day after the 
repeated dose of the drug revealed the values of different parameters. The increase and 
decrease in the values obtained were  all within the normal biological and laboratory 
limits. 
Biochemical investigation interpretation 
The biochemical investigations were conducted on 28th day and the result was 
produced. The results revealed there was no significant changes in the values of different 
parameters with that of the control. All the values were within the normal biological and 
laboratory limits. 
Histopathology interpretation 
 Histopathological study of the organ such as heart, kidney,liver,spleen and stomach 
were normal in control and all test groups.  
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Table 18 : Body wt of wistar albino rats exposed to Indhuppu bhavanai for 90 days 
 
NS- Not Significant, **(p < 0.01),*(p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test 
Table 19: Haematological parameters of Wistar albino rats group exposed to 
Indhuppu bhavanai for 90 days 
Category Control Low dose Mid dose High dose 
P value 
(p)* 
Haemoglobin(g/dl) 12.53±0.31 12.7±0.59 12.63±0.45 12.78±0.67 N.S 
Total WBC 
(cells/cu.mm) 
11.2±4.02 11±0.54 11.15±5.12 11.4±6.37 N.S 
Platelets lkhs/µl 351±.21 367±25 387.05±26 36±33 N.S 
Total RBC 
(cells/cu.mm) 
7.25±0.3 7.08±0.3 7.13±0.2 7.16±0.3 N.S 
PCV% 37.59±0.95 38.29±0.18 37.9±1.34 38.36±2.05 N.S 
MCHC g/dl 30±3.03 33.66±1.86 31±1.22 30.5±0.07 N.S 
MCV%ft 92.16±2.62 91.3±3.75 92.3±1.98 91.5±1.89 N.S 
MCH pg 30± 3.03 32.75±1.86 31±1.22 30.5±0.07 N.S 
N.S- Not Significant, **(p < 0.01), *(p <0.05), n = 6 values are mean ± S.D (One way    
ANOVA followed by Dunnett’s test) 
DAYS 
Weight(gms)/Days 
P value (p)
* 
Control Low dose Mid dose High dose 
1 161.6±33.68 148.1 ± 21.11 156.6± 13.57 159.5± 28.75 NS 
15 172.8 ± 28.87 162.5 ± 21.71 166.7 ± 29.01 166.8 ± 32.13 NS 
30 181.8 ± 28.31 175.71 ± 14.88 181.8 ± 32.11 181± 28.94 NS 
45 204.5± 27.73 194.5± 29.76 204.7± 19.75 208.3± 22.75 NS 
60 218.6±33.68 214.6±23.68 226.6±33.68 215.6±23.78 NS 
75 236.8 ± 26.85 226.8 ± 28.87 241.8± 28.87 224.8 ±26.87 NS 
90 248.5± 27.32 239.5± 27.68 251.4± 27.32 236.3± 36.32
 
NS 
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Chart 11: The mean value of HB, Total RBC, Total WBC of control and treated 
groups of wistar albino rats exposed Indhuppu bhavanai for 90 days 
 
 
Chart 12: The mean value of Platelets of control and treated groups of wistar albino 
rats exposed Indhuppu bhavanai for 90 days 
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Chart 13:The mean value of PCV, MCHC, MCV, MCH of control and treated  
groups of wistar albino rats exposed Indhuppu bhavanai for 90 days 
 
 
Table 20: Blood sugar test of Wistar albino rats group exposed to  Indhuppu 
bhavanai for 90 days 
PARAMETERS CONTROL LOW DOSE MID DOSE 
HIGH 
DOSE 
P Value 
(p)* 
Bl.sugar (mg/dl)  118.30±8 126.5±6.28 112.6±16.1 121±20.9       N.S. 
 
N.S- Not Significant, **(p < 0.01), *(p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
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Chart 14:The mean value of Blood sugar of control and treated groups of wistar  
albino rats Indhuppu bhavanai for 90 days 
 
 
 
Table 21: Lipid profile test of Wistar albino rats group exposed to Indhuppu 
bhavanai for 90 days 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
P Value 
(p)* 
Sr.TC(mg/dl) 108.±8.3 114.83±12.93 115.6±8.28 112.83±6.76 N.S 
Sr.TG(mg/dl) 129.83±2.4 136.55±9.35 4132.5±9.73 136.5±9.31 N.S 
HDL (mg/dl) 38.5±1.64 41.16±4.40 42.69±2.04 42.83±4.02 N.S 
LDL(mg/dl) 44.66±9.30 50.83±12.54 44.16±8.68 43.66±7.33 N.S 
VLDL(mg/dl) 25.66±1.25 27.3±1.87 26.4±2.01 27.3±1.86 N.S 
 
N.S- Not Significant, **(p < 0.01), *(p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
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Chart 15:The mean value of Sr.TC, Sr.TG of control and treated groups of wistar 
albino rats exposed Indhuppu bhavanaifor 90 days 
 
 
Chart 16:The mean value of HDL, LDL, VLDL of control and treated groups of 
wistar albino rats exposed Indhuppu bhavanai for 90 days 
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Table 22: Liver Function Test of Wistar albino rats group Indhuppu bhavanai for 90 
days 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
P Value 
(p)* 
T.BILIRUBIN(mg/dl) 0.86±0.04 0.79±0.1 0.75±0.1 0.80±0.13 N.S 
SGOT(IU/L) 21.6±5.08 22.5±9.97 27.6±9.09 26.15±2.04 N.S 
SGPT(IU/L) 27±5.9 30.8±5.45 28.5±3.72 31.57±10.9 N.S 
ALP (IU/L) 82.83±17.56 79.8±12.09 79±15.7 75.3±17.84 N.S 
 
NS- Not Significant, **(p < 0.01), * (p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
Chart 17: - The mean value of Bilirubin of control and treated groups of wistar  
  albino rats Indhuppu bhavanai  for 90 days 
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Chart 18:The mean value of SGOT, SGPT, ALP of control and treated groups of 
wistar albino ras exposed  toIndhuppu bhavanaifor 90 days 
 
 
Table 23 Renal Function Test of Wistar albino rats group Indhuppu bhavanai for 90 
days 
Parameters Control Low dose Mid dose High dose 
Urea (mg/dl) 32 30.16 28.3 26.5 
Creatinine 
(mg/dl) 
0.48 0.5 0.51 0.53 
 
NS- Not Significant, **(p < 0.01), * (p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
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Chart 19:The mean value of  Urea of control and treated groups of wistar albino rats 
exposed  to Indhuppu bhavanai for 90 days 
 
Chart 20:The mean value of Creatinine of control and treated groups of wistar 
albino rats exposed  to Indhuppu bhavanai for 90 days 
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HISTOPATHOLOGICAL STUDIES OF VARIOUS ORGANS AFTER THE 
REPEATED DOSE 90 DAY ORAL TOXICITY STUDY OF INDHUPPU 
BHAVANAI IN WISTAR ALBINO RATS 
 
           Control - Heart         High dose - Heart 
   
            
        Control - Kidney          High dose - Kidney 
    
 
                Control- Liver          High dose - Liver 
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           Control - Spleen         High dose - Spleen 
   
        
        Control - Stomach    High dose - Stomach 
    
 
INTERPRETATION FOR HISTOPATHOLOGICAL SLIDES OF INDHUPPU 
BHAVANAI FOR 90 DAYS 
Kidney 
 Appearance of glomerular architecture was normal in control and glomeruli 
showing striking lobular architecture in sample high dose. Cortex and medulla 
appears normal opening of lumen appears normal 
 Increased glomerular permeability was observed. 
Heart 
 Cardiac muscle appears continuous with intact nucleus 
 Myocardial tissue appears normal with orderly striated heart muscle fibers and a 
clear nuclear and muscle bands. 
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Liver 
 Central vein appears prominent with no sings of cellular infiltration 
 Hepatocellular architecture, including hepatic sinusoid and hepatic cord was 
normal 
Spleen  
 Marginal vascular zone radiated in between red and white pulp 
 No signs of f immunological activities 
Stomach 
 Mucosal epithelium appears normal with no signs of ulceration 
 Microscopic analysis of stomach of both the sample reveals anatomy of muscular 
stomach with epithelial layer keratinized stratified squamous epithelium, Lamina 
propria and Sub-mucosa 
 Gastric wall architecture appears normal. 
 
RESULTS OF REPEATED DOSE 90 DAYS ORAL TOXICITY STUDY 
Repeated dose 90 days oral toxicity study of Indhuppu bhavanai on rats were 
conducted. All animals from the treated dose survived throughout the dosing period of 90 
days. No abnormal behavioural signs were observed during the study period. 
The result of the body weight of rats exposed to control and the trial drug of 
different dose groups exhibited over all mild weight gain throughout the dosing period of 
90 days.  
The haematological and bio chemical investigations were conducted on 91 st day 
after the repeated dose of the drug revealed there is no significant changes in the values of 
different parameters with that of the control.  
Histopathological study of the organ such as heart, kidney, liver, spleen and 
stomach were normal in control and test groups. 
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PHARMACOLOGICAL ACTIVITY OF INDHUPPU BHAVANAI FOR 
ANTI –ULCER ACTIVITY 
 
Table :24   Effect of Indhuppu bhavanai (IB) on volume of gastric juice 
Group 
no 
Body wt.gms Treatment 
Vol.of gastric 
juice 
Ph
 
I 170.8±0.75 
Control (distilled water 
2ml/kg) 
5.28±0.20 2.27±0.19 
II 172.13±0.33 
Negative control (Aspirin 
500mg/kg) 
6.63±0.18 1.74±0.06 
III 171.5±1.38 
Standarddrug ranitidine 
(20mg/kg)+ Aspirin 
1.91±0.38** 5.26±0.11** 
IV 171.5±1.4 
IB - 200mg/kg + Aspirin 
 
4.33±0.24* 2.90±0.48 
V 172.2±0.41 
IB - 400mg/kg +Aspirin 
 
2.46±0.24** 4.11±0.10** 
Effects are statistically significant. *P<0.05;**P<0.01 (in comparison with standard). 
Values are expressed in terms of mean ± SEM of 6 rats (ANOVA). 
 
Chart  21Effect of Indhuppu bhavanai on volume of gastric juice and pH 
 
Control Aspirin 
(500mg/kg)
Ranitidine 
(20mg/kg)
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101 
 
Table 25   Effect of Indhuppu bhavanai on Free acidity and Total acidity 
 
Group 
no 
Body wt. gms Treatment Free acidity Total acidity 
I 170.8±0.75 
Control(distilled water 
2ml/kg) 
20.22±0.97 31.84±2.04 
II 172.13±0.33 
Negative control (Aspirin 
500mg/kg) 
23.87±0.86 46.67±1.36 
III 171.5±1.38 
Standard drug 
(Ranitidine- 20 mg/kg) + 
Aspirin 
16.14±0.19** 22.66±1.01** 
IV 171.5±1.4 IB -200mg/kg +Aspirin 18.17±0.09* 29.33±0.34* 
V 172.2±0.41 IB – 400mg/kg +Aspirin 17.18±0.14** 27.13±0.17** 
 
Values are expressed in terms of mean±SEM of 6 rats(ANOVA). Effects are stastistically 
significant *P<0.05;**P<0.01 ( in comparison with standard) 
 
Chart :22Effect of Indhuppu bhavani on Free acidity and Total acidity 
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Table26  Effect of Indhuppu bhavanai on Ulcer index and Percentage of ulcer 
protection 
 
Group 
no 
Body wt.gms Treatment Ulcer Index 
Percentage of 
ulcer 
protection 
I 181.3±1.5 
Control distilled water 2 
ml/kg 
6.6±0.26 _ 
II 182.1±2.0 
Negative control(Aspirin 
500mg/kg) 
7.4±0.50 23.5 
III 181.5±0.84 
Standard drug-Ranitidine 
(20mg/kg)+Aspirin 
1.25±0.17** 91.5** 
IV 181.83±1.6 IB- 200mg/kg+Aspirin 3.45±0.37* 54.5 
V 181.3±1.63 IB – 400 mg/kg+ Aspirin 2.21±0.24** 75.5* 
 
Values are expresses in terms of mean ±SEM of 6 rats (ANOVA).  
Percentage protection = ( Contol meanulcer index – Test mean ulcer index )/Control 
meanulcer index X 100. 
 Effects are statistically significant. *P<0.05;**P,0.01 (in comparison with Standard) 
 
Group I - Control  
Group II - Negative control received aspirin (500mg/kg) 
Group III - Standard drug ranitidine + Aspirin (500mg//kg) 
Group IV - Indhuppu bhavanai 200mg/kg + Aspirin (500mg//kg) 
Group V - Indhuppu bhavanai 400mg/kg + Aspirin (500mg//kg) 
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Chart 23    Effect of Indhuppu bhavanai on Ulcer index 
 
 
Chart 24     Effect of Indhuppu bhavanai on percentage of ulcer protection 
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HISTOPATHOLOGICAL SLIDES OF OPEN EXCISED STOMACH IN ASPIRIN 
INDUCED GASTRIC LESIONS MODEL 
 
            a. Control      b. Negative control 
   
 
 
 
 
 
              c. Standard drug – Ranitidine                         d. IB 200mg/dl 
 
  
  
   
 
 
 
e. IB- 400mg/dl 
 
 
 
 
 
 
a.Inhibition of gastric lesions at control 
b.Gastric lesions induced by Aspirin (500mg/dl) 
c. Absence of gastric lesions in Ranitidine (20mg/kg) 
d. Fractional inhibition of gastric lesions at Indhuppu Bhavanai (200mg/kg) 
e. Fractional inhibition of gastric lesions at Indhuppu Bhavanai (400mg/kg) 
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Results of Anti- ulcer (Hyperacidity) activity of Indhuppu bhavanai (IB) in wistar 
albino rats 
Gastric volume 
 The gastric volume was increased in aspirin induced group when compared to 
control group. Administration of ranitidine and  IB  showed a significant (p<0.01) 
decrease in gastric volume level, when compared to negative control. 
pH. 
 The pH level was decreased (p<0.01) in the aspirin induced method, when 
compared to control group. Administration of Ranitidine and  IB showed a significant 
(p<0.01) increase in pH level, when compared to negative group animals. Results were 
showing Table 24. 
 
Free and total acidity 
 The free acidity (mEq/L/100g) was increased (p<0.01) in the aspirin induced 
animals, when compared to control group. Administration of IB and ranitidine showed a 
significant (p<0.01) decrease in free acidity, when compared to negative control. 
 Total acidity (mEq/L/100g) was increased (p<0.01) in aspirin induced model, 
when compared to control group. Administration of ranitidine and  IB showed a 
significant (p<0.01) decrease in total acidity, when compared to negative control. 
Conclusion 
Indhuppu bhavanai exhibited anti ulcer activity in aspirin induced  ulcer model for 
screening anti ulcer drugs. The percentage of inhibition of ulcer was 91.5%, 54.5%, 75.5% 
produced by the treatment of standard drug Ranitidine, Indhuppu bhavanai (IB) at the 
dose level of 200mg/kg and 400mg/kg respectively. In case of vehicle control, aspirin 
induced rats showed increase in acid secretion, which in turn caused increase in gastric 
volume, low pH, increased free and total acidity resulting in increase of ulcer index. 
  Indhuppu bhavanai (IB) when administered at dose level of ( 200mg/kg and 400 
mg/kg) produced a  reduction in the gastric fluid volume, free acidity, total acidity and 
ulcer index significantly in comparison with control group.  
 Hence, based on the results, it can be concluded that the Indhuppu bhavanai, 
significantly p<0.05 and p<0.01,decreased the ulceration in Aspirin induced  ulcer  model 
in rats which suggest a direct ulcer protective effect on the gastric mucosa at the dose 
level of 200mg/kg and 400mg/kg respectively. The result was represented in table 26. 
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Table  27 : Effect of Indhuppu bhavanaion cotton pellet induced granuloma model 
Groups Treatment 
Mean wet 
weight of 
pellet(mg) 
Percentage 
inhibition 
Mean dry 
weight of 
pellet(mg) 
Percentage 
inhibition 
I 
Control 
 
191.16±1.60 0 40.60±0.12 0 
II 
Dexamethasone(0.5
mg/kg) 
 
92.5±3.39* 51 22.4±1.64* 44.2 
III 
Indhuppu 
bhavanai(200mg/kg) 
 
154.66±3.78 20.15 35.4±0.26* 11.94 
IV 
Indhuppu 
bhavanai(400mg/kg) 
 
152.50±3.45* 19.37 30.2±1.20* 24.87 
N= 6, values are expressed as mean± SEM P<0.05 when compared with control. The 
results were analyzed by ANOVA followed by Dunnet’s test (P value less than 0.05 was 
considered as statistically significant). 
Table 25  :Effect of Indhuppu bhavanaion the mean wet of cotton pellet induced 
granulomamodel 
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Table  26 :Effect of Indhuppu bhavanaion percentage inhibition on wet   cotton pellet 
induced granuloma model 
 
Table 27 :Effect of Indhuppu bhavanaion mean dry of cotton pellet induced 
granuloma model 
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Table 28 :Effect of Indhuppu bhavanaion percentage inhibition on dry cotton pellet 
induced granuloma model 
 
 
 
RESULTS  
The results indicate that Indhuppu bhavanai at the dose level of 200mg/kg and 
400mg/kg produced a decrease in wet granuloma weight154.66±3.78 (20.15% inhibition) 
and 152.50±3.45*(19.37% inhibition)respectively when compared to control. Similarly 
there was a significant decrease in dry granuloma weight 35.4±0.26*(11.94% inhibition) 
and 30.2±1.20*(24.87% inhibition) respectively compared to control. Among the two 
doses 400 mg/kg showed slightly lower reduced weight of granuloma than standard drug  
which was showed in table 27. Thus it was concluded that administration of Indhuppu 
bhavanai at the dose of 400 mg/kg exhibited significant (p<0.05) anti-inflammatory 
activity in Cotton pellet granuloma model of inflammation in rats. 
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Table28 :Pharmacological analysis – Analgesic activity of Indhuppu bhavanaiin Swiss 
albinomice 
Groups Treatment 
Reaction time in sec 
0min 30min 60min 90min 120min 150min 
I Control 2.32±0.11 2.52±0.03 2.42±0.04 2.40±0.01 2.39±0.01 2.38±0.04 
II 
Pentazocine 
(5mg/kg) 
2.04±0.18 4.01±0.81 8.41±0.36 
11.52±0.37
** 
11.63±0.39
** 
10.87±0.63*
* 
 
III 
Low 
dose(200m
g/kg) 
2.18±0.46 3.63±0.36 4.80±1.11 4.80±1.11* 5.22±0.24 5.15±0.42 
IV 
High dose 
400mg/kg). 
2.24±0.21 3.40±0.77 5.42±0.85 
6.01±1.13*
* 
8.22±0.24*
* 
7.80±0.26 
 
N= 6, values are expressed as mean± SEM P<0.05 ,P<0.01 whencompared with control. 
The results were analyzed by ANOVA followed by Dunnet’s test (P value less than 
0.01was considered as statistically significant 
Table 29 :Analgesic activity of Indhuppu bhavanai by Eddy’s hot plate method 
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Result of Analgesic activity of Indhuppu bhavanai in swiss albino mice 
Analgesic activity was carried out by Eddy’s Hot plate method.Indhuppu bhavanai 
at the two doses 200 mg/kg showed significant (p<0.05)analgesic activity at reaction time 
90 min (4.80±1.11*) and 400 mg/kg showed significant (p<0.01)analgesic activityat  120 
min (8.22±0.24**) was slightly lower than the standard drug Pentazocine 11.63±0.39**. 
From these results it was obvious that Indhuppu bhavanai has significant analgesic 
activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Discussion 
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9. Discussion 
 
The drug  Indhuppu bhavanaiwas selected from the Siddha literature “Kadukkai 
vallaraiin thani maanbu” to validate the safety and  its pharmacological activities (Anti 
ulcer, anti-inflammatory and analgesic) in animal models.   
 
The ingredients of the test drug was identified and authenticated by Siddha experts. 
The drug was prepared as per the procedure and subjected to various studies such as 
qualitative, quantitative, toxicity and pharmacological activities. Qualitative analysis 
includes Chemical analysis and Physicochemical properties of Indhuppu bhavanai. 
 
 Quantitative analysis included ICP-OES and HR SEM analysis to reveal its 
potency and effectiveness against the disease. 
 
From the above analysis we came to know the presence of active ingredients 
responsible for its activity. 
 
Literary collections: 
 Literary collections include drug review, which consist of both Botanical aspect, 
Gunapadam aspect, Pharmacological review that supported the study. 
 
Chemical analysis: 
          Chemical analysis of the drug Indhuppu bhavanai revealed the presence of Iron, 
Sulphate, Chloride,  Calcium, tannic acid and alkaloid. 
 
Sulphate : 
            Sulphate gives strength to the mucous membrane of the stomach, intestine and also 
promote the appetite. 
 
Chloride : 
             It regulates the water balance by maintaining the osmotic pressure of the body 
fluids and helps in the formation of Hcl in gastric juice which reduces the gastric 
problems. 
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Calcium : 
 Calcium in the form of calcium carbonate is anantacid. It is anabsorbable antacid, 
which neutralizes the gastric acid medium. 
 
Tannic acid:  
The properties of tannic acid was hardening the mucous membrane to exert a 
protective effect and it has anti- ulcer (Hyperacidity) property. 
 
These chemical elements present in Indhuppu bhavanai enhances the anti -ulcer 
activity of the drug. 
 
Physico chemical analysis 
In physico chemical analysis, the pH of Indhuppu bhavanai was found to be in the 
range of 3.91. This shows the acidic nature of the medicine. Thus it can be easily absorbed 
from the gastrointestinal tract on oral administration.  
 
The acid insoluble ash value denotes the drug quality. The drug possess with in 
normal value (0.1%) of acid insoluble ash indicating that the preparation did not contain 
any sand, dust and stones. 
The loss on drying value of Indhuppu bhavanai was found to be 6.01%w/w, hence 
the drug will not lose much of its volume on exposure to the atmospheric air at room 
temperature.  
The microbial load analysis confirms Indhuppu bhavanai was free from microbial 
organisms and fungal infections. 
 
In ICP-OES study, heavy metals were found below detection limit in Indhuppu 
bhavanai. Calcium, Potassium, Sodium, Phosporous were present. 
 
In HR SEM analysis, the particle size of Indhuppu bhavanai showed irregular 
morphology and distributed in near nano range. Indhuppu bhavanai has particle size of  
0.06 to 0.15µ.This ensures the absorption of the drug was more active and the drug have 
increased bio-availability. 
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Toxicological studies: 
 
 In acute oral toxicity study, there were no abnormal signs and behavioral changes 
in rats upto the dose level of 2000 mg/kg body weight administered orally. No mortality 
was observed in all groups. All the vital organs were normal.In Repeated dose 28 day oral 
toxicity and Repeated dose 90 day oral toxicity study, the experimental animals were 
sacrificed by excessive anesthesia and blood samples were collected and sent for 
investigation. There were no significant changes in body weight, food and water intake, 
hematological parameters, renal parameters, Liver function test , Lipid profile and blood 
glucose level. The organs were collected and sent for histopathology study. It revealed the 
organs such as heart, kidney, liver, spleen and stomach was normal in Control, Mid dose 
and High dose. Thus the toxicological study of the test drug greatly establishes the safety 
and gives the justification for long time administration. 
 
Pharmacological studies: 
The pharmacological study was carried out in the animal model Wistar albino rats 
and mice. Three activities were seen in the drug Indhuppu bhavanai. The activities were 
Anti -ulcer (Hyperacidity) 
Anti -inflammatory  
Analgesic  
Anti- Ulcer activity (Hyperacidity) 
    Indhuppu bhavanai (IB) when administered at dose level of ( 200mg/kg and 400 
mg/kg) produced a  reduction in the gastric fluid volume, free acidity, total acidity and 
ulcer index significantly in comparison with control group.Hence, based on the results, it 
can be concluded that the Indhuppu bhavanai, significantly decreased the ulceration in 
Aspirin induced ulcer in rats which suggest a direct ulcer protective effect on the gastric 
mucosa at the dose level of 200mg/kg and 400mg/kg.  
 
Analgesic activity 
Analgesic activity was carried out by Eddy’s Hot plate method. Analgesic effect 
lasted for a period of 120 min was found to be possess significant(p<0.01) analgesic 
activity at the dose level of 400mg/kg by increase in reaction time (Increase threshold 
potential of pain). From these results it was obvious that Indhuppu bhavanai has 
significant analgesic activity. 
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Anti inflammatory activity 
Administration of Indhuppu bhavanai at the dose of 200 mg/kg and 400 mg/kg 
exhibited significant p <0.05 anti inflammatory activity in Cotton pellet granuloma model 
of inflammation in rats.  
From the discussion, it was concluded that the test drug  Indhuppu bhavanai was a 
safe and a potent drug for Pitha Gunmam (Hyperacidity). 
  
 
 
Summary 
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10. SUMMARY 
 The test drug Indhuppu bhavanai was selected from the siddha literature 
“Kadukai vallaraiin thani maanbu” for its anti-ulcer (Hyperacidity), anti-
inflammatory and analgesic activities. 
 
 The test drug was prepared  by the given procedure. All the ingredients  were 
identified and authenticated by the experts. 
 
 Review of literature in various categories were carried out.Siddha aspect, botanical 
aspect and mineralogical aspect disclosed about the drug and the disease 
 
 The drug was subjected to analysis such as physicochemical, phytochemical, 
chemical and also instrumental analysis which provided the key ingredients  
present in the drug thus it accounts the efficacy of the drug 
 
 Toxicological study was made according to OECD guidelines comprising  acute, 
sub-acute  and sub chronic toxicity study. It screens  the safety of the drug which 
attributes its utility in long time administration.. 
 
 Pharmacological study revealed that the drug Indhuppu bhavanai exhibited  
significant anti –ulcer (Hyperacidity), anti inflammatory and analgesic activity in 
animal models. 
 
 From the results and the statistical analysis it was proved that the drug Indhuppu  
      bhavanai has,  
1. Anti-ulcer 
2. Anti inflammatory  
3. Analgesic activity  
4. No side effect 
5. No adverse effect 
 
Hence the trial drug Indhuppu bhavanai was safe for clinical trial. 
 
 
 
  
 
 
Conclusion 
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11.CONCLUSION 
 
From the literature evidence, Physico chemical analysis, chemical analysis, 
Toxicological evaluation and Pharmacological studies, the drug Indhuppu bhavanai have 
anti-ulcer, anti-inflammtory and analgesic activity. It was concluded that the Indhuppu 
bhavanai can be used in the management of Pitha gunmam( Hyperacidity) 
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12. ANNEXURE  
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